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Oral cancer comprises a group of malignancies involving the tissues of the lips and
oral cavity. Oral cancer is common in humans and is consistently reported as being
among the ten most frequently occurring cancers (Parkin et al 1993). There have been
recent reports that the mortality from this form of cancer is increasing (Macfarl ane et
at 7994a; Zheng et at 1999; Su et al 1999). Globally, there is considerable geographic
variation in the overall incidence of oral cancer. In most Western countries oral cancer
accounts for less than 5Vo of all cancer cases, whereas in India it has been reported
that up to 4OVo of al malignancies occur in the oral cavity'
The pattern of oral cancer in South Australia has not been examined in any detail for
over 15 years (Roder and Wilson 1983). The purpose of this study was to carry out a
review of the epidemiology of oral cancer in South Australia from 191'7-1996.
Baseline epidemiological data fbr this study were provided by the Central Cancer
Regisrry Unit of the Epidemiology branch of the South Australian Health
Commission. This population-based cancer registry was established in 1977 and
collects cancer data for the state of South Australia. Statutory cancer registration
procedures enacted in 7976 mean all new cases of oral cancer are notified to the
registry. Population statistics are also available from the Australian Bureau of
Statistics. These data were analysed to give population-based incidence and mortality







A total of 4054 cases of oral cancer were reported to the South Australian Cancer
Registry between l9l1-1996. Of these cases, 2956 (72.97o) occuned in males while
l09S (21.17o) occuned in females. The vast majority of oral malignancies were
squamous cell carcinomas (88.0Vo) and there was an increasing incidence with age.
The average age at diagnosis for oral cancer was 59.3 years in males and 66.0 years in
females. The most common site of occurrence was the lip (2716 cases, 67.07o),
followed by the tongue (454 cases , II.2Vo), major salivary glands (302 cases, T .4Vo),
other and unspecified parts of the mouth (286 cases,7.|Vo), floor of the mouth (226
cases, 5.6Vo) and the gum (70 cases, 1.7Vo).
Population-based incidence rates in both sexes showed that the overall "oral cancer"
rates were dominated by lip cancer. There was a statistically significant increase in the
incidence of lip cancer in South Australia over the 2}-year period in both sexes. In
males this appears to have plateaued in the past decade, although in females it
continues to increase. Incidence rates for the other sites are quite low and stable in
both sexes. Mortality rates for otal cancer in this state are low and stable.
The study also reviews the epidemiology of oral cancer in South Australia from a
global perspective. It shows that although the incidence of cancer in the intraoral and
salivary gland sites are relatively low in global terms, lip cancer incidence in South
Australia is amongst the highest in the world in both sexes. The rapid and sustained
increases seen in females, is an area of particular concem. This study also highlights
the importance of clearly defining the term "oral cancer" and the importance of
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Oral cancer is a unique condition involving the tissues of the lips and oral cavity. It is
common in humans and is consistently reported among the ten most frequently
occurring malignancies (Parkin et al 1993). There have also been recent reports that
mortality from this form of canceris increasing (Macfarlane et al l994a,Zhenget al
1999, Su et al 1999). While in Western countries it is generally recognised that the
prevalence of oral cancer is greater in males and increases with age (Johnson 1991),
the global pattern is far from uniform. In most Westem countries oral cancer accounts
for less than 5Vo of all cancer cases, whereas in India, 40Vo of cancers occur in the oral
cavity. This huge geographic variation in the overall incidence of oral cancer is
staggering and it is likely that a number of the site-specific racial patterns are linked
to cultural habits (Smith 1919). There is also significant sub-site variation between
countries, with high rates of lip cancer reported in Australia, Canada and Spain, while
intraoral cancer is more frequent in India and France (Parkin et al l99l).
Researchers and clinicians would agree that oral cancer can usually be detected and
treated early because of its accessible site, but this is not always the case. In
developing countries, the majority of cases arrive at health care facilities when the
disease is at an advanced stage (McMichael 1984). Late diagnosis significantly
reduces survival rates and increases post-treatment morbidity. It has also been
observed that survival rates from oral cancer decrease the more posterior the tumour
is located in the oral cavity, giving lip cancer a much better prognosis than tumours
located in the floor of mouth or base of tongue (Gerson l99O1' Caplan 1993).
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Sankaranarayanan et al (1996) summarised the widely accepted theory that oral
cancer is the outcome of a multi-step carcinogenic process. This has been
conceptually divided into three phases: initiation, promotion and progression.
Initiation involves irreversible damage to DNA by carcinogens. Promotion is the
process by which the initiated cell is converted into a pre-neoplastic or cancerous cell'
Progression occurs when defects in differentiation and growth control, and increased
resistance to host immunity allow uncontrolled proliferation of tumour cells. The
various phases of carcinogenesis have been highlighted by molecular, cytological,
parhological and clinical studies (Todd et al 1997). The authors propose that "pre-
cancerous lesions", such as leukoplakia, submucous fibrosis and dysplasia, represent
the promotion phase, while in situ and invasive carcinomas correspond to the
progression stage. This theory also endorses the older concept of field cancerization
which assumes that the whole upper aerodigestive epithelial tract is prone to the
carcinogenic process due to repeated exposure to carcinogens leading to malignant
transformation at various times. As a consequence, certain sites where potential
carcinogens tend to accumulate or pool along with saliva, for example, the floor of the
mouth and ventro-lateral surfaces of the tongue, are Seen aS more prone to developing
oral cancer
The pattern of oral cancer in South Australia has not been examined in any detail for
rhe pasr 15 years (Roder & Wilson 1933). In this study a literature review that broadly
summarises world trends in oral cancer in recent years is presented. This global
picture is used as a basis for comparison with the pattems of oral cancer in South





Epidemiology is basically a science of observation and has been defined by Lowe and
Kostrewski (1973) as the "the study of the factors determining the frequency and
distribution of disease in human populations". These authors list the three main aims
of epidemiological studies as being:
1) to describe the size and distribution of the disease problem in human populations,
2) to provide the data essential to the planning, implementation, and evaluation of
services for the prevention, control, and treatment of disease and to the setting up
of priorities among those services, and
3) to identify aetiological factors in the pathogenesis of disease.
Although the literature concerning oral cancer is voluminous, there is still much that
is not undcrstood about thc disease process. While the trends in occurrence in
different regions may suggest different patterns of disease, it is becoming generally
accepted that oral cancer involves a multi-step carcinogenic process (Speight 1993;
Sankaranarayanan 1996; Todd et al 1997).
An important observation from the recent literature is the paucity of epidemiological
studies carried out in those areas where oral cancer incidence is greatest. Oral cancer
is the dominant malignancy in many areas of South East Asia, particularly India, but
there is far more data on the incidence and mortality of this disease in 
'Western
countries. Apart from the well established registries in southem India, there is little
reliable, population based data for most of South East Asia and the islands of Papua
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New Guinea and Melanesia. There are also relatively few cancer registries in South
America and almost none in the entire African continent.
The puqpose of this review is to briefly examine the epidemiology of oral cancer on a
global scale. This will allow meaningful comparisons to be made with the situation in
South Australia over the past 20 years.
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2.2 Epidemiological Studies - Methods and Definitions
Before describing the epidemiology of oral cancer, some basic terrns and concepts
must be defined (Binnie & Rankin 1988a; Prahbu et al 1992:, Esteve et al 1994).
Prevalence is the number of cases of a disease occurring in a specific population at a
given point in time.
Incidence is the number of new cases of a disease occurring in a specific population
during a specified interval of time. By convention in cancet studies, incidence is
expressed as the number of new cases per 100,000 people per year. Incidence rates
are often presented as age-specific rates based on 5-year age groups. An age-adiusted
incidence rate is a weighted average of the age specific rates set against a standard
population usually a world standard population. This allows more meaningful
comparisons between different population groups although such comparisons must
always be made with some caution (Smith 1992a).
Mortality refers to the number of deaths due to a disease in a general population or
community (that is not just among cases). Again, this is generally expressed as a rate
per 100,000 people per year.
Survival provides a measure of the lethality of a disease. Two calculations have been
suggested. The first more crude method is to compare the number of deaths with the
number of annual registrations (D/R ratio) (Binnie 1976; Hindle & Nally 1991). The
second more commonly used measure is the 5-year survival rate, usually given as a
percentage of total number of cases, for example, a 5-year survival rate of 257o means
that in a group of patients with a particular disease, only 25Vo will survive longer than
five years from the time of diagnosis.
Cumulative rate is a newer statistic that provides an approximation of the risk of
developing a disease before a particulff age, in the absence of moftality (Day 1916).
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Epidemiological studies can be broadly divided into three main groups:
1. Descriptive studies
Descriptive studies focus on the occurence of a disease in a particular population and
its subgroups. They outline prevalence, incidence and mortality rates and attempt to
show trends in disease patterns. It is best seen as the first stage of the investigatory
process allowing generation of hypotheses without aspiring to verify them (Esteve ef
al 1994). Within these studies there is scope to investigate disease patterns in terms of
time trends (eg. age, period and cohort models) and geographical variations.
2. Analytical studies
Analytical studies are designed to test causal hypotheses with the aim of identifying
aetiological agents in a disease process. Case-contt'ol or retrospective studies use a
representative sample of cases and controls examining historical information, usually
in the form of questionnaire surveys or interviews, in an attempt to discover possible
aetiological agents in the disease process. Longitudinal or prospective studies begin
with individuals selected according to exposure or non-exposure to the suggested
causative factor. These groups are then followed prospectively and their disease
incidence rates are compared. These studies result in the calculation of values such as
relative risk (a measure of the association between exposure to a particular factor and
the risk of developing the disease) and attributable risk (the incidence of a disease
among exposed individuals due to the exposure). A major difficulty with analytical
studies is separating out a single risk factor from a group of other potential factors to
which the individual is exposed. This is particularly important in the case of oral
cancer where tobacco and alcohol are commonly investigated and, in many cases,
heavy drinkers are also heavy smokers. To draw conclusions in these studies involves
a series of complicated mathematical calculations that are often difficult, if not
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impossible, to verify. These problems aside, analytical studies remain the major
epidemiological technique for testing causal hypotheses in a disease process.
3. Experimental studies
Experimental studies are longitudinal, prospective, follow up or cohort studies where
the researcher has control over who is exposed to the suspected causal factor and
when this exposure occurs. In the case of oral cancer and other potentially life-
threatening diseases there are serious ethical problems with experimental studies.
An important consideration in any cancer study is the reliability of data. The
establishment of cancer registries in many locations around the world has served to
highlight the crucial need for accurate reporting of cancer cases and as Jensen ¿/ ¿/
(1990) point out, "cancer registration is the basis for any rational programme of
cancer control". In some areas, including South Australia (McMichael & Bonett
1981), cancer registration is mandatory for all hospitals, haematology and pathology
laboratories and these areas are usually shown to have reliable and accurate statistics.
However, in other locations, such as England, cancer notification is not compulsory
and data are consequently less reliable. Commenting on the likelihood of under-
reporting of oral cancer in the United Kingdom, Langdon (1991) observed that "the
mechanisms for recording cases are by no means watertight". This problem was
subsequently confirmed in a study of oral cancer registration in south-east England,
where Warnakulasuriya et al (7994) suggested that national incidence rates for mouth
cancer may have been underestimated by about 25Vo. In the United States, the key
source of cancer statistics is the Sut'veillance, Epidemiology, and End Results (SEER)
program. The SEER team obtains cancer information from nine geographic areas
across the United States covering approximately 9.3Vo of the total population, and this
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is believed to provide a representative sample of the entire population (Percy et al
1995). However, in a recent study to assess under-registration of oral cancer at the
Connecticut Tumor Registry during the period 1984-1988, Morse et al (1995) found
fhat 27o of known oral cancer cases in Connecticut were not registered with the
central body.
Access to and maintenance of accurate death notification facilities is another crucial
tool in descriptive epidemiological studies and the reliability of death certificates is
crucial in determining mortality rates and survival statistics. Kelson and Farebrother
(1987) investigated the effect of inaccuracies in death certification and coding
practices on international cancer mortality statistics. Their findings showed signifìcant
discrepancies within and between countries leading these authors to conclude that a
degree of caution is needed when making epidemiological comparisons. The results of
this study were supported by Percy and Muir (1989) who reported on the international
comparability of cancer mortality data.
The establishment of an increasing number of population-based cancer registries
allows a greater degree of standardisation and dissemination of epidemiological data.
Publication of volumes such as Cancer Incidence in Five Continents (now in its 7th




2.3.1 The Aetiology of Oral Cancer
The aetiology of oral cancer has been extensively studied over the past four decades.
A warershed article in aetiology was published by Wynder et al (1957) and since that
time there has been extensive epidemiological research aimed at identifying risk
factors for and clues into the cause(s) of oral cancer. Recent research is particularly
focussed on the molecular biology of oral carcinogenesis (Scully 1993a;Paterson et al
1996 Wong et at 1996; Todd et al 7991), with particular interest in the role of
oncogenes and tumour suppressor genes in this process. Most authors would
recognise that oral carcinogenesis is a multistep, multifactorial process, involving a
number of possible environmental and host factors. It is not the intention of this
review to focus on the aetiology of oral cancer, although a brief reference to possible
causes and risk factors will be presented.
Tobacco
Tobacco habits have long been associated with oral cancer. In'Western countries, this
is mainly in the form of smoking, although concerns have been raised over the
increasing use of chewing tobacco and snuff, particularly by younger people (Squier
1984; Depue 1986; Merne et al1998). In a recent reappraisal of smokeless tobacco in
the United States, Vigneswaran et al (1995) concluded that its use carries a lower risk
of oral cancer than smoking. The World Health Organisation has concluded that there
is "sfficient evidence that tobacco smoke is carcinogenic to humans" (WHO 1986)
and the vast majority of studies and reviews return to tobacco smoking as the most
significant risk factor in oral cancer (see Table 1).
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Review article (United States)Smith (1917)
Review articleSmith (1989)
IndiaSankaranarayanan et al (1990b)
Review articlePindborg (1911)
UruguayOregsia et al (1991)
DenmarkMoller (1989)
Review articleMcMichael (1984)
New South WalesMcCredie et al (1990)
Review articleMashbers and Samit (1989)
United States, Italy and ChinaMacfarlane et al (1995a)
UtahLyon et al (1911)
TaiwanLt et al (1996)
ItalyLa Vecchia et al (1988)
ThailandKo er al (1995)
NetherlandsJovanovic et al (1993b)
Review articleJohnson and Warnakulasuriya 1993
Review articleHindle et al (1996)
Republic of IrelandHerity et al (1981)
Northem ItalyFranceschi et al (1990b)
kanFahmy et al (1983)
CanadaElwood er al (1984)
New ZealandCox et al (1995)
DenmarkBundsaard et al (1994)
Review articleBoyle et al (1988)
United StatesBlot et al (1990)
France (Doubs region)Andre et al (1995)
Country/Location of studyAuthor(s)
Table 1. A selection of recent studies and review articles that implicate tobacco
smoking in the aetiology of oral cancer.
In many non-westem countries, the widespread cultural practice of chewing tobacco
as part of the betel quid or pan has been strongly linked to the formation of oral
cancer (WHO 1985; Nandakumar 1990; Sankaranarayanan 1990a; Sankaranarayanan
et al 1990b; Ko et al 1995; Lu et al 1996; Chen et al 1999). According to
Sankaranarayanan (1990a) these practices are often linked to cultural beliefs about the
medicinal benefits of betel leaves and other ingredients of the quid, while Wllson et al
(1992) note that it may also be used as a religious offering or payment to priests, as
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part of ceremonies involving contractual negotiations or as a sign of respect or regard.
These strong cultural ties mean primary prevention through control of the habit will
likely prove a difficult if not impossible task.
Reichart et al (1990), reporting on oral cancer in Northern Thailand, noted a fall in the
incidence of oral cancer in recent decades that paralleled the disappearance of many
of the tradìtional chewing and smoking habits. Similar observations have been made
in Bombay, India, where bidi smoking and tobacco chewing have decreased (Jayant &
Yeole 1987) and in Hanoi, Vietnam, where the betel chewing habit is declining (Pham
et at 1993). These studies provide further evidence of the importance of tobacco in its
various forms, as a key aetiological factor in the development of oral cancer.
Alcohol
Alcohol consumption is another factor commonly linked to oral cancer. Many of the
studies examining tobacco usage (see Table 1) have also studied the effect of alcohol
on the development of oral cancer. While there seems to be general agreement that
alcohol is an important risk factor, it is often difficult to separate out its relative
importance since many studies have shown that heavy drinkers are also heavy
smokers. Some researchers (Elwood et al 1984; Mashberg et al 1989; Moller 1989;
Andre et at 1995) found alcohol to be more significant than smoking, although most
studies lean more heavily towards tobacco as the major risk factor. A number of
researchers (Herity et al 7981;B\ot et a|7988; Franceschi et al l990b;Ko et al1995)
claim to have demonstrated a synergistic or multiplicative effect of alcohol and
tobacco acting in combination in the development of oral cancer. Blot et al (1988)
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proposed that smoking and alcohol account for approximately l5Vo of all oral and
pharyngeal cancers in the United Statcs.
There has been some suggestion in the literature (Winn et al l99l) that alcohol found
in commercially available mouthwashes might be an additional risk factor for oral
cancer. A recent review (Elmore & Horwitz 1995) examined seven published studies
of this possible aetiological factor carried out between 1916-1995. These researchers
concluded that "neither the data for the overall association nor the analysis in patients
without other clinical risk factors support a link between mouthwash use and oral
cancer".
Oral health status
Although for many years clinicians and researchers have suggested that oral cancer is
related to poor oral health, there is limited epidemiological evidence to substantiate
this association (Graham et al 1977). While it is feasible that broken teeth and/or
restorations, poorly fitting dentures and other sources of chronic irritation may
contribute to the development of oral cancer, the difficulties in quantifying these
facrors mean it will always be difficult to establish this as a definite risk factor.
Diet and nutrition
Epidemiologic studies have consistently shown that oral cancer patients have lower
than average nutritional status, while regular ingestion of certain foods, especially
fresh fruits and vegetables, seems to provide a protective effect. (Herity et al 1981;
Winn et a|1984; Mclaughlin et al1988; Moller 1989; La Vecchia et al 7993a;Zheng
et at 7993', Macfarlane et al 7995a). Brookes and Clifford (1981) linked nutritional
l2
status with general immune competence to show how these factors were important
prognostic indicators for patients diagnosed with head and neck cancer.
In recent years, research has turned to the prophylactic use of nutrients and
micronutrients in the chemoprevention of cancer (Hakama et al 1996; Stewarf et al
1996). Chemoprevention has been defined as "intervention in the process of
carcinogenesis with dietary or chemical agents with the aim to prevent or delay the
development of cancer" (de Vries et al 1992). The agents commonly suggested are
vitamin A (retinoids) and antioxidants such as N-acetylcysteine (NAC), beta-carotene
& vitamin E (Scully & Boyle 1992). Naturally occurring a7gae, such as Spirulina
fusiformis that are rich in a number of micronutrients, are also being investigated
(Sankaranarayanan et al 7996). Chemoprevention trials against cancers of the head
and neck are cuffently underway, for example, EUROSCAN (de Vries ¿r al 1994).
These studies are focusing on chemoprevention of second primary tumours as
opposed to the traditional management of intensified screening programs and the
preliminary results appear promising. If successful, chemoprevention may become an
extremely effective primary prevention strategy in developing countries where oral
cancer remains a major health problem.
Socioeconomic status
While income and education have been suggested as risk factors for oral cancer
(Smith 1919), there is very little data to substantiate these claims (Douglass er a/
1984). It does seem feasible, however, that socioeconomic status may be linked to the
nutritional factors discussed above, a point expanded further by Macfarlane et al
(1996) in their discussion of increasing trends of oral cancer in Scotland. Elwood and
t3
Gallagher (1935) have also demonstrated that patients with a higher socioeconomic
status were more likely to have oral cancer diagnosed in the early stages of the
disease. In this study, early diagnosis of oral cancer was also linked to regular dental
care and low levels of alcohol consumption.
Familial or genetic factors
According to Boyle et al (1995), oral cancer does not tend to cluster strongly in
family groups, but Ankathll et al (1996) in a recent pedigree analysis from India
found some evidence of family aggregation. These authors proposed an autosomal
dominant mode of inheritance for an "oral cancer susceptibility gene". Cannon-
Albright et at (1994) demonstrated unusually high levels of familial clustering for lip
cancer in Utah between 1961-1911. These authors conceded that this observation may
primarily reflect environmental influences, such as an increased exposure to
ultraviolet radiation, but the possibility of inherited susceptibilities could not be ruled
our. Merrick et al (1936) also reported familial clustering of salivary gland
carcinomas in Greenland, and proposed that genetic predisposition might play an
important role in the development of this form of oral cancer. Gorsky et al (1994) also
showed clear ethnic links in oral cancer incidence, while other researchers (Hamner
1986; Steele & Shillitoe 1991; de Vries et al 1992) firmly believe that genetic
susceptibility (for example, chromosome fragility and oncogene activation) plays an
important role in oral carcinogenesis. Recent molecular studies appear to confirm this
rheory (Wong et at 1996: Todd et aI 7997). Goldstein et al (1994) demonstrated a
slightly increased risk for developing oral cancer in individuals who had family
members with oral cancer, but they concluded that this familial tendency is most
likely related to environmental factors, especially smoking and drinking.
t4
Viruses
Viruses have been implicated in the development of cancer in other squamous
epithelia, most notably cervical carcinoma, so it has been postulated that they also
play an important role in oral carcinogenesis. Using modem techniques of gene
mapping, a number of viruses have been studied including Epstein-Barr virus (EBV),
cyromegalovirus (CMV), herpes simplex virus (HSV) and human papilloma virus
(HPV). Some researchers (Steele & Shillitoe 1991; Scully 7993a) are of the opinion
that viruses play a significant role in the aetiology of oral carcinoma, although a
recent review article examining the role of high risk human papillomaviruses in oral
carcinogenesis concluded that the evidence is "mainly circumstantial" (Sugerman &
Shillitoe 1991).
Radiation
Elevated exposure to ultraviolet/actinic radiation has been frequently linked with lip
cancer (V/urman et al 79'15; Lindqvist 1979; Douglass er al 1984; Brownson ¿t a/
1989; Blomqvist er at 1991 Pukkala et al 1994; Awde et al 1996; Schouten er a/
1996; de Visscher & van der Waal 1998). Other forms of irradiation have been
proposed as significant risk factors in the development of salivary gland tumours
(Spitz et al 1984; Horn-Ross et al1997).
Occupation
Various outdoor occupations such as farming, fishing and labouring are commonly
proposed as important risk factors in the development of oral cancer, particularly of
the lip. This association is usually related to elevated exposure to solar radiation
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(Spitzer et at l9l5; Lindqvist and Teppo 1978; Lindqvist 1979; Douglass and
Gammon 1984; Brownson ¿/ al 1989; Pukkala et al 7994; de Visscher & van der
Waal 1998). Other occupations have been suggested as important in the aetiology of
oral cancer, but an extensive study over 15 years in Finland (Pukkala et al 7994),
concluded that the role of direct occupational factors was "minimal". Huebner et al
(1992),in a large case-control study from the United States in 1984-1985, reached the
same conclusion that occupation plays only a relatively small role in the pathogenesis
of oral and pharyngeal cancer.
Conclusion
The aetiology of oral cancer is complex and the exact nature and pathogenesis of the
disease is far from established. Scully (1993a) and others are most likely correct when
they conclude that oral carcinogenesis must be the result of an interaction between a
variety of environmental factors (for example, chemical carcinogens, vituses) and
host mechanisms (for example, genetic susceptibility, host defences/nutrition status).
According to Smith (1919), the ultimate goal for epidemiological research into oral
cancer must be the "recognition of aetiological factors, removal of their influence, and
measurement of a resultant significant decline in oral cancer mortality and incidence
ratgs",
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2.3.2 The Epidemiology of Oral Cancer
In studying oral cancer, researchers have discovered that its long latency period and
relatively low incidence render cause and effect relationships difficult to establish
(Binnie & Rankin 1938). This is further complicated by the fact that recent
discoveries continue to point to oral cancer as having a multistep, multifactorial
aetiology (Scully 1993a; Sankaranarayanan et al1996; Todd et al1997). On the other
hand, the fact that this disease has a high fatality rate and relatively high degree of
diagnostic reliability allows the generation of quite accurate population data that is
essential for descriptive studies.
The epidemiology of oral cancer does, however, present some important challenges to
both the clinician and researcher. Unlike other areas of the body, the boundaries of the
oral cavity are not easy to define. As a consequence, the exact definition of oral
cancer has proved to be a difficult task. A number of authors (Smith 1979; Boyle et al
1990; Sankaranarayanan 199Oa; Jovanovic et al 7993a; Moreno Lopez and Esparza
Gomez 199S) have emphasised the importance of precisely defining the expression
"oral cancer", while also noting the diversity in terms and definitions used in joumal
articles, textbooks and scientific reports. To highlight the extent of this problem,
Table 2 summarises some of the different terms and definitions used when referring to
"oral cancer" in recent publications. The coding system outlined in the 9th revision of
the International Classffication of Diseases (ICD-9) (WHO l91l) has been used to




140-9Oral cancerZhens. et al (7998)
r41.143-6, t48-9Oral and pharyngeal cancerWinn ¿r al (1991)
740: 142: 141.143-5Lip; Salivary; Other oralSwerdlow et al (1995a)
r40-9Oral and pharyngeal cancerSmith (1979)
140-5Oral cancerRoder&Wilson(1983)
145-8Pharynx
140.141.143-4Lip, tongue and oral cavityPukkala et al (1994)
140-5Oral cavityPham et al (1993)
140-9Oral cavity and pharynxParkin et al (1993\
140-1. 143-6, 148-9Oral cavityOstman et al (7995)
141.143-5Tongue and oral cavityMoller (1989)
140-5Buccal cavitvMcMichael et al (7989)
t41,143-6,148-9Mouth and pharynxMcCredie et al (1995)
140-9Oral cancerMcCartan & Crowley (1993)
140.3-5, 14r,743-5,
146.2
Oral carcinomaMashberg et al (7989)
141. 143-6,148-9Mouth and pharynx
r40-9Oral cavitv and pharynxMacfarlane et al (1996)
747, 143-6,148-9Oral cancerMacfarlane et al (1995b)
140.3-5, 141.143-6Oral cancer
t4t. t43-6,148-9Oral cancer(Summaris es thre e studie s)
141,143-5Oral cancerMacfarlane et al (1995a)
141,143-5Intraoral cancer
143-5Mouth cancerMacfarlane et al (1992)
t40-9Oral cancerLa Vecchia et al (1997)
t40-9Oral cavitv and pharynxLa Vecchia et al (1992)
140-1,143-5Oral cancerKo et al (1995)
140-r,143-5Oral cancerJohnson & Warnakulasuriya (1993)
t40-9Buccal cavity and pharynxJensen et al (1990)
141,143-6Oral cancerHindle et al (1996)
140-6,149Oral cancerHindle & Nally (1991)
Not definedOral cancerHamada et al (7997)
t41.143-5Oral cavityGrulich et al (7992)
141,743-6,148-9Oral and pharyngeal cancerGoldstein er al (1994)
Not definedOral cancerGazit et al (1984)
140-1.143-5.149Tongue and oral cavityFranceschi et al (1992b)
140-1.143-5Tongue and oral cavityFranceschi et al (1990b)
140-1,743-5Oral tumoursFaye-Lund & Abdelnoor (1996)
141,743-6,148-9Oral cancerDav et al (1994)
140-9Oral cancerCox et al (1995)
t40-9Oral cancer
143-5Mouth cancerBovle et al (7990)
140.3-5, 741, 743-5Oral cancerBoffetta et al (1994)






Table 2. Examples of the different terrns and definitions used to describe "oral





This summary serves to illustrate the magnitude of the nomenclature problem
associated with "oral cancer" and demonsÍates some instances where the same author
has used a different term or definition in different papers. Unfortunately there seems
to be no simple solution to this dilemma and comparison of individual studies must
always be carried out with some degree of caution.
Muir and Staszewski (1990) concisely outlined the advantages and disadvantages of
grouping sites in oral cancer studies. Decreasing the number of sites reduces some of
the classification problems and increases the number of cases for study in the broader
diagnostic categories. It also eliminates a problem commonly encountered with oral
cancer, namely the determination of the primary site. Boyle et al (1990) also referred
to this problem when they noted that categorising oral cancer into subgroups may
prevent a clinician from assigning a precise location to a tumour that extends over a
number of anatomic structures. Chen et al (1990a) also noted the difficulties that may
arise in mapping large lesions. The main disadvantage with combining sites is that
aggregation of cancers having different biological and epidemiological characteristics
results in the loss of much information (Smith 1989; Oreggia 1991). As Muir and
Staszewski (1991) pointed out, the distortion resulting from a broad grouping is
especially pronounced for populations with an extremely high incidence of one of
these cancers. Chen et al (1992) demonstrated an important example of this problem
when they showed how combining lip cancer data with intraoral cancer data under the
broader category of "oral cancer" can distort or mask the data relating to "intraoral
cancer". Other authors (Smith 1913; Smith 1919; Smith 1989; Morse et al1999)have













In this review and subsequent investigation of the South Australian data, "oral cancer"
is defined as lip (140 ICD-9), tongue (141 ICD-9) and mouth (143-5 ICD-9)'
Although salivary gland tumours (142 ICD-9) will also be included, their unique
pathology and epidemiology indicates that they should probably be considered as a
separate form of cancer. There is also compelling evidence in the South Australian
data that lip cancer (140 ICD-9) should be considered separately from other forms of





2.3.3 Oral Cancer - World Data
Bearing in mind the epidemiological problems of comparing statistics on oral cancer.
this section attempts to synthesise the world data relating to oral cancer incidence and
mortality trends. The review begins with data on oral cancer drawn from studies
where all subsites are combined. This is followed by a more focused comparison of
individual oral subsites, using cancer atlases or maps as a guide. The statistics for
these incidence maps have been captured lrom Cancer Incidence in Five Continents,
Volume VII (Parkin et at 7997) and figures are given as rates per 100,000 per year,
age-standardised to a world population. In the text these data are supplemented by
references to more specific epidemiological studies and reviews.
The majority of studies on oral cancer have found that, with the exception of salivary
gland tumours, squamous cell carcinoma is the dominant histopathological type
(Smith 1979; Walton et at 1991; Daftary et al 1992: Muir & Weiland 1995). Oral
cancer usually occurs more frequently in males, although some researchers have noted
a decrease in the male/female ratio in recent years (Gazit 1984; Devesa et al l98l;
Chen et al 1991 Barasch et al 1995: Devesa et al 1995; Hindle et al 1996). This is
explained by a fall or plateauing in the male incidence rate, combined with increasing
incidence in women.
In general, oral cancer is a disease of the elderly with the average age at diagnosts rn
the sixrh or seventh decade (Krolls and Hoffman 1916; Johnson 1991). A number of
authors have highlighted increasing incidence and mortality trends for oral cancer
(Macfarlane et al 1994a). While these increases are seen particularly in younger





1981: Jensen et at 1990; Franceschi et al I992a; Macfarlane et al 1992;Boyle et al
1993; Coleman et at 7993; Biorklund and Wennersberg 7994; Devesa et al 1995;
Hindle et al1996), this does not seem to be a uniform global pattem.
Mo¡tality from oral cancer is site dependent with a trend of decreasing survival as the
primary site moves more posteriorly in the oral cavity. This means that cancers of the
lip show much better 5-year survival (80-9OVo), than those of the floor of mouth, base
of tongue or sofr palate (30-40Vo) (Renson 1990). Gerson (1990) referred to certain
areas of the mouth where saliva tends to pool, thereby keeping the oral mucosa in
contact with potential carcinogens for longer periods of time. These more susceptible
intraoral areas that have been called the "gutter zone" (Johnson and'Warnakulasuriya
1gg3) are also generally covered by a non-keratinised epithelium, theoretically
making penetration by carcinogens easier.
In addition to primary site, survival rates are also closely linked to the extent of the
initial lesion. While spread to regional nodes adversely affects five-year survival
rates, the presence of distant metastases reduces five-year survival to 27Vo or less
regardless of site - lip excluded (see Table 3).
73052Oropharynx (146)
2049t1Gum and other mouth (143,145)
2744IJFloor of Mouth (144)
113165Tongue (141)
8293Lip (1a0)
114015Oral cavity and Pharynx (140-9)
Distant metastasesRegional nodesLocal
Primary Site Five-ye ar survival (%)
Table 3. Summary of the impact of the extent of lesion on the five-year survival rate
of oral cancer (Gerson 1990).
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In a study on data from the Connecticut cancer registry, one of the oldest population-
based registries in the world, Chen et al (1990a) showed oral cancer rates in males
falling from 14.5 per 100,000 per annum in the late 1930's to 4.1 per 100,000 per
annum in the early 1980's. During this time they also observed a significant fall in the
male/female ratio due primarily to a rise in the female incidence rate. The Connecticut
trends have been confirmed in a more recent study (Morse et al 7999) and are
duplicated elsewhere in the United States. In California, Walton et al (1991) reported
a decrease in oral cancer, particularly lip cancer. Devesa et al (7987), in a broader
epidemiological study of a number of areas of the United States, found rates for
cancer of the mouth and pharynx were rising in females while the overall male rates
remained stable. The relatively stable age-adjusted incidence rates, however, have
been shown to mask differing trends by age group. While decreases occurred among
older age groups, for example, those over 85, increases occurred among males aged
45-64. According to La Vecchia et al (1993b), mortality rates for oral and pharyngeal
cancer in Canada and the United States have remained relatively stable in both males
and females between 1955-1989.
There is little published data concerning oral cancer in South America although Junior
et at (1994) presented preliminary statistics for oral carcinoma and potentially
malignant lesions in Brazil. Reviewing trends in cancer mortality in the Americas
between 1955-1989, La Vecchia et al (1993b) found a heterogenous pattern for oral
and pharyngeal cancer; to improve comparability all oral and pharyngeal sites (140-
149 ICD-9) were grouped together. Puerto Rico and Cuba reported high mortality
rates for oral cancer (around 10 per 100,000 per annum) in the 1960's. Subsequently
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rates have remained stable in Puerto Rico, fallen in Cuba, and risen in Argentina and
Uruguay.
In a global review of the epidemiology of mouth cancer in 1989, Boyle et al (1990)
found high male incidence rates in France (range 6.9-13.5) and India (range 6.5-8.0),
while Northern and Eastern European countries and some Asian population groups
(Japanese and Chinese), showed the lowest rates. In contrast to these findings, Lu et
at (1996) reported a relatively high and rising incidence rate of 4.5 per 100,000 per
annum for oral cancer in males in Taiwan. Boyle et al (199O) also reporled that the
incidence of oral cancer was decreasing in many areas including the United States,
Australia and Czechoslovakia, while there were significant increases in some of the
Nordic countries. On the other hand, these researchers found that the mortality from
oral cancer was increasing in a number of regions, a fact supported by La Vecchia er
at (1992) in their extensive review of cancer mortality in Europe from 1955-1989.
The results of Jensen et al (1990) supported the broad geographic trends of cancer
incidence and mortality in the European Community, when they reported high rates in
France, Luxembourg and Italy and low rates in Greece and the Netherlands from
1978-1982. These investigators showed that oral and pharyngeal cancer is the third
most common form of cancer in French males (33.9 per 100,000 per annum) only
exceeded by lung and prostate cancer, and that it has the second highest mortality rate
in men (19.2 per 100,000 per annum) after cancer of the lung. Jensen et al (1990) did
not find however, the increases in mortality reported by La Vecchia et al (1992).
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Examining oral cancer in England and'Wales between 1900-1990, Hindle et al (1996)
observed that oral cancer mortality peaked in the 792O's and then declined until the
mid-1970's. Although the overall rate has remained stable since then, more detailed
analysis has revealed an upward trend in both incidence and mortality rates for
younger age groups. Scotland has higher incidence and mortality rates for oral cancer
than England and 'Wales (Johnson and 
'Warnakulasuriya 1993), and Macfatlane et al
(1992) found rhat the Scottish rates are increasing. This significant upward trend has
occurred since the mid-1970's and once again this rise seems particularly pronounced
among younger age groups. A similar cohort-linked increase has also been observed
in Denmark (Moller 1989). In an extensive study of oral cancer in Sweden from 1960-
1989, Ostman et al (1995) found a slight increase in incidence rates although the
trends were not consistent across the various sites.
Plesko et at (1994) reported a steady increase in the incidence of oral and pharyngeal
cancer in Slovakia in males from 1968 -89. Zaridze and Basieva (1993) reported high
incidence rates for cancer of the mouth and pharynx in males in 1989 in the
Commonwealth of Independent States, the Baltic States and Georgia. The overall
incidence rate for males in the former USSR was 15.7 per 100,000 per annum'
indicating that the mouth and pharynx was the third most common cancef site after
the lung and stomach. The female rate was much lower at2.7 per 100,000 per annum.
No time trends were given in this report'
Macfarlane et al (1994a) analysed national datasets in 24 countries to assess changes
in cancer mortality from 1950-1990. These authors demonstrated a pattem of
increasing cohort-linked oral cancer mortality in men that was particularly
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pronounced in Central and Eastern Europe. This finding is supported in a more recent
study by La Vecchia et al (7997), where Hungary, Germany FRG and Romania show
the greatest increases in oral cancer mortality for males between 1955-1959 and 1990-
7992. Zatonski ¿f at (1996) also report "a dramatic increase of mortality in males" for
cancer of the oral cavity and pharynx in Central Europe since the mid-1960's.
For many years, oral cancer has been recognised as a major health problem in India.
The oral cavity is the most frequent site for cancer in India with Pindborg (1977)
reporting that in excess of 457o of all cancers occur at this site. More recent studies
from various cancer hospitals in India reveal a frequency ranging from 15-207o for
oral cancer relative to all cancers, with male incidence rates ranging from 11.0 to 25'0
per 100,000 per annum (Sankaranarayanan 1990a). The high incidence rates for oral
cancer in India are frequently linked to tobacco chewing habits. It is interesting to
note that migrant studies reveal an increased risk for oral cancer in ethnic Indians
even afrer they have immigrated to the United Kingdom (Swerdlow et al 1995b).
Elsewhere in Asia reported oral cancer rates are lower, with Hanoi, Vietnam
recording a male incidence rate of 2.2 per 100,000 per annum (Pham et al 1993).In
two recent studies of oral cancer mortality trends in Japan, however, St et al (1999)
and Zheng et al (7999) have reported increasing mortality rates in males between
1950-1994 and 1950-1993 respectively. These results confirmed the findings of an
earlier study (La Vecchia et al 1993c), although these authors had combined all sites
of the oral cavity and pharynx (140-749ICD-9) in their analysis.
In Australia the trends are not clear. Macfarlane et al (1994b) studied oral and
pharyngeal cancer in New South Wales between 1972-1990 and found that despite an
26
increase in incidence rates during the mid-1970's and early 1980's, this trend has not
continued. Conversely, McCredie et al (7995) reported an increase in both incidence
and mortality rates for the same sites between 1973 and 1992. These authors proposed
a number of reasons for this increase, including increased detection/earlier diagnosis,
changing diagnostic practices, changing registration procedures and a changing
prevalence of risk factors. La Vecchia et al (1993c) reported increasing mortality rates
for cancer of the mouth and pharynx in Australian males from 1955-1989, particularly
those aged 35-64 years. Data from South Australia (Roder & Wilson 1982) showed
high oral cancer rates for males, with nearly 65Vo of these lesions being lip cancer.
The earliest reported studies on oral cancer in Australiaare a series of articles by Tan
(1969; 1910a: 1970b). However, these are based on medical case histories and
provide little comparable population-based data.
According to a recent study by Cox et al (1995), oral cancer in New Zealand is
becoming a more serious problem. These authors found a significant increase in the
incidence rates for all subsites of oral cancer in both males and females and reported
that mortality has also increased in New Zealand between 1955-199l.LaYecchia et
al (1993c) also reported increases in mortality rates for cancer of the mouth and
pharynx in New Zealand males between 1955-1989. As with the Australian data,
these increases were particularly pronounced in the cohort aged35-64.
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2.3.3.1 Lip Cancer 140 (ICD-9)
Lip cancer is a unique form of oral cancer occurring at the junction between the oral
cavity and the skin. As a consequence, the reliability of data conceming lip cancer is
ofren confused by difficulties determining the precise site of origin. The majority of
these lesions arise on the vermilion border ("lipstick zoÍre"), that is, the area between
the labial mucosa and the dermis of the lip. While most of these cancers are recorded
as oral cancer, there is the potential that some will be classified as skin cancer.
Macfarlane et at (1993) refered to this potential classification problem noting that in
the case of large lesions it may be impossible to determine the exact site of origin of
the tumour. To eliminate this risk in South Australia, lip cancer figures include the
skin of lip subsite (113.0ICD-9). It should be noted, however, that this practice has
the potential to elevate the South Australian figures. Morton et al (1983) observed the
"ambiguity and non-uniformity" in the literature regarding lip cancer and referred
back to a definition by Ebenius from 1943: "No other cancer than that arising in the
red ofthe lip should be regarded as genuine lip cancer".
Regardless of the difficulties defining the primary site of lip cancer, the general trends
reveal that it occurs more often in men, has a peak occurrence in the sixth and seventh
decades, and is more common on the lower lip than the upper lip (Fahmy et al 1983;
Chen et at 1992; Daftary et a|7992; Antoniades et al1995; Ostman et al 7995; Faye-
Lund & Abdelnoor 7996; de Visscher et al 1998; Morse et al 1999). It is frequently
seen in men employed in outdoor activities, for example, farming, fishing and
labouring. Although these observations have led to the suggestion that sunlight is a
key factor in the pathogenesis of lip cancer (Spitzer et al 1975; Lindqvist & Teppo
1978; Lindqvist 1919 Douglass & Gammon 1984; Smith 1989; Pukkala et al 1994;
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Antoniades et al 1995; de Visscher & van der Waal 1998), not all researchers agree
(Szpak et al 1977).
According to Daftary et al (1992), the common initial signs and symptoms of lip
cancer are ulceration, encrustation and soreness. These features have led some
researchers (Blomqvist et at I99l) to suggest that recurrent viral infection may also
play a role in its pathogenesis, but no definite link has been established.
Advanced lip cancers present as extensive ulcerative and/or infiltrative lesions, but the
overall growth rate is relatively slow. Lymph node metastasis is rare and, because of
the accessible site of these lesions, wide excision is usually curative giving well
differentiated lip cancers an excellent five-year survival rate of 80-90Vo (Gerson l99O;
Renson 1990; Antoniades et al 1995; Muir &. Weiland 1995). Johnson and
Wamakulasuriya (1993) reported a five-year survival rate approaching 95Vo, for lip
cancer in the United Kingdom.
While the lip is the most common site for oral cancer in many while male populations,
the disease is relatively rare in black males (Lindqvist 1979; Binnie & Rankin 1988b;
Parkin et al 1992; Parkin et a|1997). This trend is reversed when other intraoral sites
are studied (See Table 4) and has been explained by the protective effects of skin
pigments against the carcinogenic action of solar radiation (Douglass & Gammon
1984).
The global trends for lip cancer incidence males are summarised in the attached maps
(Figures 1-5). As previously mentioned, lip cancer is generally more common in
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males than females. It should be pointed out, however, that a number of researchers
have reported a decrease in the male to female ratio for lip cancer in recent years
(Chen et al 1992; Cox et al 1995; Ostman et al 7995). This trend has been explained
in part by a fall in the male incidence rate, but in some cases it is also due to a
concurrent rise in the female rates.
North America
a. Male
Available data (Figure la) show comparatively high rates of lip cancer in males for
most of Canada, peaking with Newfoundland at 72.1 per 100,000 per annum. While
this is one of the highest rates in the world, it is considerably less than the rates
reported for this region and other areas of Canada in the late 1960's and 1970's.
Between 1963-1966, the reported rate of lip cancer for males in Newfoundland was
28.6 per 100,000 per annum (Doll er al 7970), while from 1969-1912 it was only
marginally lower at 2l.l per 100,000 per annum (Waterhouse et al 1976). Elevated
rates were also reported elsewhere in Canada at this time, for example Saskatchewan
27.6 per 100,000 per annum and New Brunswick 18.3 per 100,000 per annum (Doll er
al 1910). More recent studies have confirmed the decreasing trend in both incidence
and mortality for lip cancer in all regions of Canada (Coleman et al 1993).
The United States shows a variable pattem of lip cancer incidence with white male
rates ranging from 0.4 per 100,000 per annum in Connecticut up to 4.4 per 100,000
per annum in New Mexico. The SEER figure is 1.9 per 100,000 per annum. More
detailed studies from Connecticut (Chen et al 1992; Morse et al 1999) and California
(Walton et al 1997) confirm that, as in Canada, overall incidence and mortality rates
30
for lip cancer in the United States are falling (Devesa et al I98l; Coleman et al 1993;
Devesa et al 1995). Data in the latest edition of Cancer Incidence in Five Continents
(Parkin et al 1997) support these observations, with all areas except Iowa reporting















Figure la. North America. Incidence of lip cancer (140 ICD-9) in white males for
selected regions of North America. Average annual age-standardised rates per
1 00,000 population (Standard World Population).
















Of all the SEER regions, Utah has shown a consistently higher incidence rate for lip
cancer over the past two decades: reported rates for males were 12.3 per 100,000 per
annum between 1966-1910 (Waterhouse et al 1916); 10.3 per 100,000 per annum
from 1973-1977 (Waterhouse et al 1982); 8.1 per 100,000 per annum between 1918-
1982 (Muir et al 1987) and 10.3 per 100,000 per annum from 1983-1987 (Parkin et al
1992). The latest reported incidence rate for lip cancer in Utah (4.1 per 100,000 per
annum), while lower than that of previous decades, is still one of the highest in the
United States. These elevated rates are in sharp contrast to the low rates of oral cancer
reported at other intraoral sites in Utah. The lower incidence of intraoral cancer in
Utah has been explained by the "unique religious and cultural background of its
residents" expressed by, for example, reduced tobacco and alcohol consumption. On
the other hand, the elevated rates of lip cancer have been attributed to the high
proportion of people engaged in outdoor occupations (Lyon et al1975).
b. Female
The incidence of lip cancer in females in North America (Figure lb) is much lower
than the male rates in corresponding populations with only one region reporting a rate
grearet than 1.0 per 100,000 per annum. In Yukon, this relatively high rate (1.6) is
based on a small number of cases with a high standard error. In a study of lip cancer
in Connecticut over a 50-year period, Chen et al (1992) noted a fall in the male to
female ratio from 1935-1985. These authors found that this was primarily due to a



































Figure 1b. North America. Incidence of lip cancer (140 ICD-9) in white females for
selected regions of North America. Average annual age-standardised rates per
1 00,000 population (Standard World Population).









The data for lip cancer in South American males (Figure 2a) is limited, but overall the
incidence appears low with only one registry, Goiania in Central Brazll, reporting a
rate greater than 2.0 per 100,000 per annum. 'Whether this reflects the real incidence
or is a function of under-reporting is not known, although the Goiania rate of 2.2 per
100,000 per annum is considerably higher than the 0.1 per 100,000 per annum
reported for the same region between 1988-9 (Parkin et al1992).
Figure 2a. South America. Incidence of lip cancer (140 ICD-9) in white males for
selected regions of South America. Average annual age-standardised rates per
1 00,000 population (Standard V/orld Population).


































The reported incidence of lip cancer in females in South America (Figure 2b) is low
with no registry reporting an incidence rate greater than 0.5 per 100,000 per annum.
Figure 2b. South America. Incidence of lip cancer (140 ICD-9) in white females for
selected regions of South America. Average annual age-standardised rates per
100,000 population (Standard World Population).












As with Nofih America, European data (Figure 3a) shows a wide variation in the







Figure 3a. Europe. Incidence of lip cancer (140 ICD-9) in white males for selected
regions of Europe. Average annual age-standardised rates per 100,000 population
(Standard World Population).


















High figures have been reported for parts of Spain (up to I2.O), Poland (6.3), Belarus
(5.8) and Southem Italy (4.6). This contrasts with the low rates in Central-Northern
Italy (0.5), Eastern France (0.2) and England & Wales (0.5).
The Nordic countries report a moderate rate of lip cancer and a recent review of the
Swedish data has shown that this rate has remained relatively stable (Ostman et al
1995). Jovanovic et at (1993a) reported that the situation in the Netherlands is typical
of countries elsewhere in that region, a finding confirmed in a more recent study (de
Visscher et al 1998). Levi et al (1993) found that the incidence of lip cancer in males
in the Vaud, Switzerland was low, and decreased between 1915-1990. According to
Antoniades et al (1995), lip cancer is the most common form of oral cancer in
Nonhem Greece (59.4Vo compared to 40.5vo for other intraoral sites), but no
population based incidence rates were given.
In the United Kingdom, higher rates for lip cancer are consistently reported for
Scotland, but in a recent analysis, Macfarlane et al (1993) reported that the incidence
is sreadily decreasing. The decline of lip cancer in the United Kingdom is supported
by Wolall (1995) (England and Wales) and Crosher and Mitchell (1995) (Scotland),
although both of these reports only provided prevalence data and not population-
based incidence rates. A surprising finding was the high rate of lip cancer (11'6)
reported in Southern Ireland between 1980-1982 (Muir et al 7987). The latest figure
(3.1) was much lower (Parkin et al 1997). Although, no explanation for this
discrepancy was found, McCartan and Crowley (1993) stated that "Previous reports of
high rates of lip cancer in Irish men can now be regarded as probably inaccurate".
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According to Coleman et al (1993), the incidence of lip cancer decreased everywhere
in Europe except for Navarra and Zaragoza (Spain) between 1913-1981. Although the
data from the latest edition of Cancer Incidence in Five Continents (Parkin et al 1997)
support this overall downward trend in Europe, increasing rates for lip cancer in
Granada, Murcia, Tarragona and Basque County are evident, while incidence has
fallen in both Navarra andZaragoza. These data also show slight increases for parts of
France. Coleman et al (7993) also pointed out that the rate of decline in Eastem
European populations is slower than in other European countries. As with North
America, the mortality from lip cancer is decreasing in most European countries (Hill
et at 1991; Hindle & Nally l99l; Johnson & Wamakulasuriya 1993;Macfarlane et al
19e3).
b. Female
The incidence of lip cancer in females in Europe (Figure 3b) is low with no regions
reporting rates greater than 1.0 per 100,000 per annum. Although in parts of Spain the
male:female ratio is greater than 15:1, in the United Kingdom and Nordic countries
the ratio is much lower. According to Ostman et al (1995), this ratio has fallen in
Sweden over the past three decades due to a combination of lip cancer incidence









Figure 3b. Europe. Incidence of lip cancer (140 ICD-9) in white females for selected
regions of Europe. Average annual age-standardised rates per 100,000 population
(Standard World Population).










Lip cancer generally has a low reported incidence in Asian males (Figure 4a), with no
regions reporting rates greater than 1.0 per 100,000 per annum. In some areas, for
example, China, Japan and Singapore, lip cancer appears to be virtually unknown
with rates of 0.1 per 100,000 per annum. Su et al (1999) andZheng et al (1999) have
reported decreasing mortality rates for lip cancer in Japan between 1950-1994 and
1950-1993 respectively. According to Coleman et al (1993), with the exception of
Bombay, these low rates are showing a negative trend, indicating that the incidence of






Figure 4a. Asia. Incidence of lip cancer (140 ICD-9) in males for selected regions of
Asia. Average annual age-standardised rates per 100,000 population (Standard World
Population).












The latest data for female lip cancer in Asia (Figure 4b) shows incidence rates greater
than male rates in some regions. This finding, which contrasts with the general global
pattern, was seen in Thailand, Vietnam, Korea and areas of India, but no explanation








Figure 4b. Asia. Incidence of lip cancer (140 ICD-9) in females for selected regions
of Asia. Average annual age-standardised rates per 100,000 population (Standard
V/orld Population).
















Oceania (Figure 5a) has an elevated incidence of lip cancer in males with areas of





Figure 5a. Oceania. Incidence of lip cancer (140 ICD-9) in white males for selected
regions of Oceania. Average annual age-standardised rates per 100,000 population
(Standard World Population).
Source: Parkin et al, Cancer Incidence in Five Continents, Volume VII (1997).
Although South Australia had the highest reported rate of 13.5 per 100,000 per
annum, registries in Western Australia (8.7) and the Australian Capital Territory (8.9)
also reported a high incidence of lip cancer. The incidence rate for lip cancer in the
ACT from 1988-1992 was almost double the 4.5 per 100,000 per annum reported





increase. The South Australian figure is considerably higher than elsewhere in
Australia and, according to Coleman et at (1993), it has increased at a rate gleater
than anywhere else in the world. Unfortunately, no data were reported from the
Queensland Cancer Registry between 1988-1992. In a sufvey of major hospitals in
Australia from 1959 - 1964, Tan (1970) estimated the rate of lip cancer in Queensland
to be 20.6 per 100,000 per annum, more than double the South Australian rate at that
time. More recenrly, Muir ¿f at (1981) reported the Queensland figure to be 10.8 per
100,000 per annum from 1978-Ig82, also greater than the South Australian figure of
9.3 per 100,000 per annum for the same period. Despite the rising trends in incidence
in many regions, mortality from lip cancer in Australia decreased between 1973-t987
(Coleman et al 1993).
New Zealand reports a relatively low incidence rate of lip cancer among the Non-
Maori male population (3.4), but a recent study by Cox et al (1995) found that this
increased between 1955-1989. These investigators showed that, along with other oral
cancer subsites, lip cancer is becoming more common in New Zealand males'
b. Female
While still lower than the corresponding rates, the incidence of lip cancer in females
in Oceania (Figure 5b) is still high in global terïns. South Australia again reported the
highest rate of 3.2 per 100,000 per annum and more recent data contirms that the
incidence of lip cancer in South Australian females continues to increase at an
alarming rate (South Australian Cancer Registry 1998; 1999). Cox et al (1995) found
a similar trend in New Zealand with the incidence of lip cancer rising faster among

















Figure 5b. Oceania. Incidence of lip cancer (140 ICD-9) in white females for selected
relions of Oceania. Average annual age-standardised rates per 100,000 population
(Standard World Population).
Source: Parkin et al, CarLcel Incidence in Five Continents, Volume VII (1997)'
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2.3.3.2 Tongue Cancer 141 (ICD-9)
The tongue is the most common intraoral site for cancer with Chen et al (1990b)
finding in excess of 407o of Connecticut cases occurred in this location. In Hindle and
Nally's study from England and Wales (1991), over 30Vo of intraoral cancers were
lingual, while Mashberg et at (7989) found a similar figure (32.67o) in a study from
Torino, Italy. Using data from the Armed Forces Institute of Pathology, Krolls and
Hoffman (1916) analysed 14,253 cases of squamous cell carcinoma of the oral soft
tissues. They found 35.2Vo of intraoral lesions occurred on the tongue.
As with other oral sites, squamous cell carcinoma accounts for the vast majority
(>957o) of lingual malignancies (Chen et al l99l; Muir & Weiland 1995; Ramirez-
Amador et al 1995). The lateral borders and base of the tongue seem to be the most
"cancer-prone" areas and, along with the floor of the mouth, make up the common
intraoral sites for cancer in most populations. Researchers have suggested that this is
due to the pooling of carcinogens carried in saliva in these oral food channels and
reservoirs (Chen et al l99}b), also referred to as the "gutter zone" (Johnson &
'Warnakulasuriya 1gg3). This theory has been called Lederman's hypothesis
(Mashberg et at 1989), and the sites most at risk are the tongue (ventral and lateral
surfaces), floor of mouth, anterior tonsillar pillar and lingual aspect of the retromolar
trigone.
Cancers of the anterior two-thirds of the tongue are usually detected earlier than those
of the posterior one-third. Cancers of the anterior two-thirds also tend to be better
differentiated, leading some researchers to suggest that tumours of the posterior one-
third are more aggressive (Daftary et al l99l). It has also been proposed that
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squamous cell carcinoma of the oral tongue in patients less than 30 years of age may
be a more virulent and aggressive form of neoplasm (Byers 1915). As with other oral
cancer sites, there is a definite male predilection for tongue cancer and in general,
incidence rates increase with age (Chen et al199Ob).
The commonly cited aetiological agents in tongue cancer are once again tobacco
(smoking and chewing habits) and alcohol (Oreggia et al 7991; Franceschi et al
1992b; Johnson & 'Wamakulasuriya 1993; Hindle et al 1996). Additional factors
suggested are nutritional deficiencies, poor dentition and viruses (Cox et al7995).
Tuming to the global patterns for incidence and mortality of tongue cancer, there are
significant geographic variations. These trends are summarised in Figures 6-10 and
will now be discussed.
North America
a. Male
Latest data indicates that North America (Figure 6a) has a relatively low incidence of
tongue cancer in males. The highest rates reported in Canada are from Prince Edward
Island (3.2), Ontario (2.4) and Quebec (2.3). However Coleman et al (1993) found


























Figure 6a. North America. Incidence of tongue cancer (141 ICD-9) in white males
for selected regions of North America. Average annual age-standardised rates per
1 00,000 population (Standard World Population).
Source: Pa¡kin et al,Cancq Incidence in Five Continents, Volume VII (1997).
The risk of tongue cancer among white males in the United States is generally low,
with only Detroit (3.2) and San Francisco (3.1) reporting rates greater than 3.0 per
100,000 per annum. Recently, however, some researchers have highlighted an
increasing incidence of tongue cancer among young males in several US populations
including Detroit, Seattle, and the Bay Area (Davis & Severson 1987; Coleman et al





as snuff and chewing tobacco among younger age groups (Squier 1984), though this
interpretation remains controversial (Vigneswaran et al 1995). In another study,
Depue (1936) has also shown that the mortality rate for cancer of the tongue ìn the
United States is rising in young, white males.
Puerto Rico has consistently reported high incidence rates for tongue cancer with 9.7
per 100,000 per annum between 1964-1966 (Doll er aI l9l0),7.5 per 100,000 per
annum from 1968-1972 (Waterhouse et al I976), 6.0 per 100,000 per annum between
1913-1971 (Waterhouse et al 1982),5.7 pet 100,000 per annum from 1978-1982
(Muir et at 1987) and 4.8 per 100,000 per annum between 1983-1987 (Parkin et al
1992). The latest incidence rate of 4.1 per 100,000 per annum between 1988-1992
(Parkin et at 7991) is still high although, as Coleman et al (1993) confirmed, the
incidence of tongue cancer in Puerto Rico is declining.
A significant observation not demonstrated on the cancer maps is the markedly
elevated incidence rates for tongue cancer among black male populations throughout
the United States (Parkin et al 1991). While the US SEER figure for white males is
2.5 per 100,000 per annum, the incidence for black males is much higher at 4.6 per
100,000 per annum. This finding, also noted by Muir and Weiland (1995), is
paralleled by other intraoral cancer ïates, and contrasts with the incidence rates for lip
cancer in white and black populations. This pattern is repeated in many areas of the
United States (See Table 4). A dramatic example of this trend was reported from
Bermuda between 1983-1987 (Parkin et al 1992), where a tongue cancer incidence
rate of 16.3 per 100,000 per annum was given for black males compared with 3.8 per
100,000 per annum in the white male population. Subsequent data from this registry
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Location Mouth (f43-5)Toneue (14L)Lip (140)
Table 4. Comparison of incidence rates for lip, tongue and mouth cancer in white and
black male populations in the United States between 1988-1992. Annual age-
standardised rates per 100,000 (World Standard Population).
Source: Parkin et al, Caîçer Incidence in Five Continents, Volume VII (1997)
b. Female
The incidence of tongue cancer among females in Norlh America (Figure 6b) is
generally low. Although a high rate of tongue cancer is reported for females in
Northern Canada, this is based on a very small number of cases and has a high





























Figure 6b. North America. Incidence of tongue cancer (141 ICD-9) in white females
for selected regions of Norlh America. Average annual age-standardised rates per
100,000 population (Standard World Population).
Source: Parkin el al, Cancer Incidence in Five Continents, Volume VII (1997).
In a study from Connecticut reviewing 50 years of data on intraoral cancer, Chen et al
(1990b) showed that the incidence of intraoral cancer in females, of which the tongue
was the most common site, has risen. This increase, combined with a plateauing of the
male incidence, resulted in a dramatic fall in the male to female ratio.
Ò
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It is interesting to observe that the sharp discrepancy for intraoral cancer incidence
between black and white male populations is not reflected in the female data. In many
areas of the United States the incidence rates for white females are not greatly
different to those of black females. In New Orleans, the rate of tongue cancer in white
females (0.98 per 100,000 per annum) exceeds that of the black female population




The rate of tongue cancer in males in South America (Figure 7a) varies considerably
with the comparatively high rates reported for Brazl7, Uraquay and Columbia
contrasting with the lower rates from countries on the Western coast.
Figure 7a. South America. Incidence of tongue cancer (141 ICD-9) in white males
for selected regions of South America. Average annual age-standardised rates per
I 00,000 population (Standard World Population).
Sowce: Parkin et al, Cancer Incidence in Five Continents, Volume VII (1997).
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Sao Paulo, Brazil, has shown elevated rates for tongue cancer over a number of
decades with 5.7 per 100,000 per annum reported in 1969 ('Waterhouse et al 7916),
5.4 per 100,000 per annum in 1973, and'7.4 per 100,000 per annum in 1978 (Muir e/
al 1987). More recent data from this region was not published in the later editions of
Cancer Incidence in Five Continents (Parkin et al 1992, Parkin et al 1997). Although
the rate of tongue cancer in other regions of Brazil (Goiania and Port Allegre) is high,
it appears to be falling. Hamada et al (7991) showed that tongue cancer contributed
28.3Vo of all cancers of the mouth and pharynx (140-149 ICD-9) in males in Sao
Paulo in 1978. This converts to 4J.5Vo of all intraoral cancers (I41, 143-145 ICD-9)
for this region.
h. Female
The incidence of tongue cancer in South America (Figure 7b) is low with all
registries, except Lima, Peru, reporting rates below the corresponding male rates.
Belem in Northern Brazll, reported a relatively high incidence rate of 7.1 per 100,000
per annum, but this is still well below the corresponding male rate. In Cali
(Columbia), Quito (Ecuador) and Lima, the male to female ratio is higher than
elsewhere in South America. Hamada et al (1991) showed that tongue cancer
contributed 74.6Vo of all cancers of the mouth and pharynx (140-149 ICD-9) in
females in Sao Paulo in 1978.
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Figure 7b. South America. Incidence of tongue cancer (141 ICD-9) in white females
for selected regions of South America. Average annual age-standardised rates per
1 00,000 population (Standard V/orld Population).




The incidence of tongue cancer varies throughout Europe (Figure 8a) with high
incidence rates reported in France (range 3.6-8.0), Slovakia (5.1) and Slovenia (3.6).
High rates are also reported for parts of Switzerland (4.8), Germany (4.1) and Italy





Figure 8a. Europe. Incidence of tongue cancer (141 ICD-9) in white males for
selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard World Population).
















France has the highest rates for male tongue cancer in Europe and Hill et al (1991)
reported that mortality rates from tongue cancer in France increased 1.8 fold between
1952-1956 and 1981-1985. The observation that tongue cancer is particularly
pronounced in France, a country with one of the highest alcohol consumptions in the
world, has led some investigators (Andre et al 1995) to the conclusion that alcohol
consumption is the major risk factor in these cases. A primary role for alcohol in the
development of tongue cancer has also been proposed by Moller (1989), Elwood et al
(1934) and Mashberg et al (1993), following studies in Denmark, Canada and the
United States respectively.
Coleman et al (1993) highlighted the most important factor concerning tongue cancer
in Europe - namely that it is increasing in most countries particularly amongst young
adult males. This trend is supported by data from the latest edition of Cancer
Incidence in Five Continents (Parkin et al 1997). The fact that both incidence and
mortality rates are rising significantly in males is also confirmed by separate studies
from England and Wales (Hindle & Nally l99l), Scotland (Macfarlane et al 1992;
Macfarlane et al 1996), France (Hlll et al l99l), Denmark (Moller 1989), Finland
(Kari et al 1991) and Sweden (Ostman et al 1995} As with recent trends in the United
States, these increases seem to be cohort-linked with those born from 1915 onwards
being at greater risk. Once again, the use of smokeless tobacco by young people has
been suggested as a possible risk factor (Macfarlane et al 1987). In a detailed study of
oral cancer in Scotland, Macfarlane et al (1996) observed that survival is lower
among people from lower socioeconomic groups and the recent increases in
occurrence have primarily occurred in these groups.
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b. Female
According to the latest data, the incidence of tongue cancer in females in Europe
(Figure 8b) is lower than that of males in all regions of Europe except Malta. An
increase in tongue cancer has been reported in many European female populations
including Scotland (Macfarlane et al 7992), England and 'Wales (Hindle & Nally
1991), France (Hill 1991), Sweden (Ostman et al 1995) and Denmark (Moller 1989).
In a recent study from the two northemmost provinces of Finland (Kari et al l99l),










Figure 8b. Europe. Incidence of tongue cancer (141 IC; in white females for
selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard V/orld Population).





















For many decades, tongue cancer, along with other forms of intraoral cancer, has been
a serious problem in India. The risk of tongue cancer in India is significantly higher
than in other locations in Asia (Figure 9a) with most population-based registries on













Figure 9a. Asia. Incidence of tongue cancer (141 ICD-9) in males for selected
regions of Asia. Average annual age-standardised rates per 100,000 population
(Standard World Population).













Between 1983-1987, a tongue cancer rate of 14.0 per 100,000 per annum was reported
for Ahmedabad in the Western Province (Parkin et al 1992), but more recent data
from this region was not published in the latest edition of Cancer Incidence in Five
Continents (Parkin et at 1997). Bombay has shown a consistently high incidence of
tongue cancer with male rates of 14.0 per 100,000 per annum between 1964-7966
(Doll e/ at 1970),72.6 per 100,000 per annum from 1968-1912 (ÌVaterhouse et al
1916),10.2 per 100,000 per annum between 1973-1975 (Waterhouse et al 7982),9.4
per 100,000 per annum from 1978-1982 (Muir et al I98l) and 7.4per 100,000 per
annum berween 1983-1987 (Parkin et al 1992). The latest data shows an incidence
rate of 6.5 per 100,000 por annum from 1988-1992 (Parkin et al 1991). Jayant and
Yeole (19S7) confirmed that the incidence of tongue cancer in males in Bombay fell
between 1964-1982. Hamada et al (1991) reported that tongue cancer contributed
44.47o of all cancers of the mouth and pharynx (140-149 ICD-9) and 57.07o of all
intraoral cancefs (141,143-145 ICD-9) in males in Bombay from 1978-1982.
The elevated rates in India are commonly linked to the betel chewing habits (Smith
1973; Jayanr & Yeole 1987; Boyle et al 1989; Sankaranarayanan et al 1989; Daftary
et al 1991). In this context, it is also interesting to note that although the rate of
tongue cancer in Singapore is low, it is elevated among the Indian sub-population and
has been for the past two decades. The extent to which this may be the result of
genetic predisposition or cultural habits cannot be easily determined. Although India
still reports amongst the highest rates of tongue cancer in the world, the overall risk
has been described as stable or falling (Coleman et al 1993). Elsewhere in Asia,
tongue cancer incidence rates are quite low and stable with the exception of Japan






incidence trend was not supported by recent mortality data from Japan. Zheng et al
(1999) reported that tongue cancer mortality rates in Japanese males remained quite
stable between 1950-1993, while Su et al (1999) found a slight fall from 1950-1994.
b. Female
The incidence of tongue cancer in Asian females (Figure 9b) is generally less than the
corresponding male incidence with only Hanoi, Vietnam reporting a female incidence
rate greater than the male rate. In some regions including The Philippines, Thailand







Figure 9b. Asia. Incidence of tongue cancer (141 ICD-9) in females for selected
regions of Asia. Average annual age-standardised rates per 100,000 population
(Standard World Population).





















The incidence of tongue cancer in males in Oceania is low (Figure 10a) with only the





Figure 10a. Oceania. Incidence of tongue cancer (141 ICD-9) in white males for
selected regions of Oceania. Average annual age-standardised rates per 100,000
population (Standard World Population).
Source: Parkin et al, Cancer Incidence in Five Continents, Volume VII ( 1997).
Using hospital records, not population-based data, Tan (1970a) reported a decrease tn
tongue cancer in Australia in the early 1960's. Limited Australian data has been
published since that study. Roder and Wilson (1982) reported a male incidence rate of
1.8 per 100,000 per annum in South Australia between 1917-1980 and the same rate is
reported between 1988-1992 (Parkin et al 1997). Coleman et al (1993) reported that
the rate of tongue cancer in Australian males remained stable between 1913-7981
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with the exception of New South Wales, where both incidence and mortality rates
increased. Macfarlane et al (1994b) believe other factors in addition to tobacco
smoking have influenced this trend, suggesting increasing alcohol and decreasing fruit
and vegetable consumption may be significant. In New Zealand, Cox et al (1995)
reported an increase in both the incidence and mortality of tongue cancer in males
between 1955-1991. They also point to factors other than tobacco and alcohol as
significant in this trend.
While it is generally known that intraoral cancer rates are high in other parts of
Oceania, particularly Papua New Guinea (Henderson & Aiken 1919) and the islands
of Melanesia (Taylor et al 7983), no reliable population-based data for tongue cancer
incidence have been published from these regions.
b. Female
The rate of tongue cancer in females in Oceania (Figure 10b) is quite low with no
regions reporting a rate in excess of 1.0 per 100,000 per annum. Roder and Wilson
(1983) reported the female incidence of tongue cancer in South Australia between
1911-1980 to be 1.2per 100,000 per annum, but the latest data shows a50Vo fall to
0.6 per 100,000 per annum from 1988-1992. Cox et al (1995) found that the rate of






Figure 10b. Oceania. Incidence of tongue cancer (141 ICD-9) in white females for
selected regions of Oceania. Average annual age-standardised rates per 100,000
population (Standard World Population).




2.3.3.3 Mouth Cancer 143-5 (ICD-9)
Cancers of the "mouth" include lesions assigned to the gingivae and alveolar ridge,
the floor of the mouth, the buccal mucosa, the hard and soft palate and the uvula and
other unspecified regions of the oral cavity. Cancer in these areas has much in
common with tongue cancer in terms of purported aetiology (See Lederman's
hypothesis earlier), appearance, physical and clinical characteristics. Histologically,
the vast majority (>957o) of lesions from these locations ale squamous cell
carcinomas (Chen et al 1990b; Daftary et al 1992; Muir & Weiland 1995; Ostman ¿/
at 1995). Not surprisingly, the global trends for mouth cancer incidence are similar to
those reported for tongue cancer, although there are some variations.
North America
a. Male
The rate of mouth cancer in North American males (Figure 11a) is high in Puefio
Rico, a number of areas in the United States, and regions of Canada. Nova Scotia in
Eastern Canada reported an incidence rate of 3.3 per 100,000 per annum, while the
Yukon registry recorded a high rate of 9.0 per 100,000 per annum. Further
investigation revealed that this figure is based on a small number of cases and the
standard error is quite high (Parkin et al 1997). According to Coleman et al (1993),
the rate of mouth cancer was stable in most parts of Canada between 1973-7981 , but
increased in the Maritime Provinces. Puerto Rico has reported consistently high rates
of mouth cancer for a number of decades: 6.7 per 100,000 per annum between 1964-
1966 (Doll et al 1970), 7.8 per 100,000 per annum from 1968-1912 (Waterhouse et al
1916),6.2 per 100,000 per annum between 1913-1971 (Waterhouse et al 1982),6.4






annum between 1983-1981 (Parkin et al 1992). The latest rate of 4.1 per 100,000 per
annum from 1988-1992 (Parkin et at 1997) confirms an earlier observation that the
risk of mouth cancer in Puerto Rico is falling (Coleman et al 1993). In the Eastem
United Srares, New Orleans (3.7), Detroit (3.6) and Connecticut (3.4) all report mouth
cancer rates above 3.0 per 100,000 per annum, while on the West Coast, high rates are













Figure 11a. North America. Incidence of mouth cancer (143-5ICD-9) in white males
for selected regions of North America. Average annual age-standardised rates per
1 00,000 population (Standard World Population).























According to Coleman et at (1993), the rate of mouth cancer in Detroit increased from
1913-lg8l. Chen et at (1990) found a similar increase in Connecticut men from 1935-
1985. The incidence rate for mouth cancer among white males in Hawaii has been
consistently high for a number of decades. Reviewing cancer trends across the entire
United States berween lgl5-1991, Devesa et at (1995) found that the incidence of
cancer of the mouth (including tongue) and pharynx (combined sites) in males had
fallen slightly (l.l%o), while the mortality had dropped by ovet 207o.
As with tongue cancer, black male populations have a significantly greater risk of
mourh cancer than white populations (See Table 4). Although the US SEER figures
demonstrate this discrepancy, the most dramatic example of this trend was again seen
in Bermuda between 1983-1987 where the incidence rate for black males was 12.1 per
100,000 pef annum, compared with 3.7 per 100,000 per annum for the white male
population (Parkin et at 1992). More recent data from this region was not published in
the latest edition of Cancer Incidence in Five Continents (Parkin et al 1991).
b. Female
The rate of mouth cancer among North American females (Figure 11b) is generally
lower than corresponding male rates. Devesa et al (1995) found that the incidence of
cancer of the mouth (including tongue) and pharynx in females in the United States
was stable between 1975-199L However, in a study from Connecticut, Chen et al
(1990) have shown a dramatic decrease in the male : female ratio for intraoral cancer,
due mainly to a sharp increase in the female incidence rate from 0.3 per 100,000 per
annum in 1935 to 3.3 per 100,000 per annum in 1980. This changing trend in sex

































The difference in incidence rates for mouth cancer between black and white female
populations in the United States is not as great as that seen in the male data. In Los
Angeles, San Francisco and New Orleans, the incidence rates for mouth cancer in






In contrast to the low incidence rates for mouth cancer in males in much of South
America (Figure l2a), Brazil reported amongst the highest rates in the world (range
3.4 per 100,000 per annum in Goiania to 5.5 per 100,000 per annum in Belem).
Figure 12a. South America. Incidence of mouth cancer (743-5ICD-9) in white males
for selected regions of South America. Average annual age-standardised rates per
I 00,000 population (Standard World Population).
Source: Parkin et al, Cancer Incidence in Five Continents, Volume VII (1997).
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According to Coleman et al (1993), the Brazilian male incidence rate for mouth
cancer continued to steadily increase from 1973-1987. Hamada et al (1997) studied
the epidemiology of oral cancer in Sao Paulo, BrazlI in 1978 and found that mouth
cancer (143-145 ICD-9) made up 3l.3Vo of all cancers of the mouth and pharynx
(140-149ICD-9) and 52.5Vo of intraoral cancel (147,143-145 ICD-!) in males'
b. Female
The incidence of mouth cancer in South American females (Figure 12b) is generally
low, although, as with the male data, rates in parts of Brazll are quite high. Hamada et
al (1991) found that in females in Sao Paulo in 1978, mouth cancer (143-145ICD-9)
made up 37.27o of all cancer of the mouth and pharynx (140-149 ICD-9) and l7.8%o
of intraoral cancers (141,143-145 ICD-9).
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Figure 12b. South America. Incidence of mouth cancer (143-5 ICD-9) in white
females for selected regions of South America. Average annual age-standardised rates
per 100,000 population (Standard World Population).




As with other oral subsites, the incidence of mouth cancer among the various









Figure 13a. Europe. Incidence of mouth cancer (143-5 ICD-9) in white males for
selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard World Population).

















Paralleling tongue cancer, France reports the highest incidence of mouth cancer in
Europe between 1988-1992 with rates ranging from 2.8 per 100,000 per annum in
Tarn to 11.1 per 100,000 per annum in Bas-Rhin. Concurrently, Hill et al (1991)
reported a steady increase in mortality rates for mouth cancer in France from 1950-
1990, although Coleman et al (1993) suggest that this may have plateaued in the
1980's. This contrasts with a falling mortality rate from lip cancer in France over the
same period (Hill et al 1991).
Other European countries at a higher risk for mouth cancer in males between 1988-
1992 are Slovenia (5.0), Slovakia (5.4) and parts of Italy (8.4), Germany (5.3) and
Spain (4.9) and the latest data seems to confirm that the incidence of mouth cancer is
increasing in many regions of Europe. Geneva (Switzerland) has shown consistently
elevated rates for mouth cancer over a number of years and, examining figures from
the Vaud cancer registry, Franceschi et al (7992a) reported a decline in five-year
survival rates for oral cancer (as well as pharyngeal and laryngeal sites). Although
recent data was not available for Hungary, an interesting observation from earlier
figures (Parkin et al 7992) is the relatively low reported rates for mouth cancer from
1983-1987 (range 1.9-2.2), when compared with the high incidence of tongue cancer
in the same regions over the same period (range 3.7-5.1). According to Coleman et al
(1993), however, the incidence of mouth cancer in Hungary has increased between
1913-t987.
Although the Nordic countries have a relatively low rate of mouth cancer (range 1.1-
1.7) compared with the rest of Europe, Ostman et al (1995) have shown a significant






Denmark lrom 1943-1985 (Moller 1989) and this trend was confirmed by Coleman er
al (1993), who claim that the risk of mouth cancer rose in all the Nordic countries,
except Finland, between 191 3-7987 .
The incidence of mouth cancer in the United Kingdom is also low (range: 1.5 per
100,000 per annum in England and Wales to 2.8 per 100,000 per annum in Scotland),
however, some researchers have reported increasing rates in Scotland (Macfarlane er
al 1992 Macfarlane et aI 1996) and Northern Ireland (Cowan et al 1992).
Nevertheless, Johnson and Warnakulasuriya (1993) point out that the total number of
cases in Northern Ireland is small. The increasing trend in Scotland is supported by
the latest data from Cancer Incidence in Five Continents (Parkin et al 1991) where the
incidence rate for mouth cancer rose to 2.8 per 100,000 per annum. A similar increase
was noted for Southern lreland. Coleman et al (1993) reported that the risk of mouth
cancer in England has not changed substantially in recent years, although Hindle et al
(1996) found significant increases in incidence and mortality for younger males
between 1960-1990.
b. Female
Throughout Europe, the incidence of mouth cancer is lower in females (Figure 13b)
than males. Some areas including Scotland, Iceland, Denmark and pafis of France
report high rates of mouth cancer in females, but these are still lower than the
corresponding male populations. ln Sweden, Ostman et al (1995) reported an increase
in cancer of the floor of the mouth in females, while rates for other parts of the mouth
have remained stable. Hindle and Nally (1991) showed an increase in both incidence






study from the United Kingdom, however, Hindle et al (1996) found that the
incidence and mortality for cancer of the oral cavity (including the tongue) had












Figure 13b. Europe. Incidence of mouth cancer (143-5ICD-9) in white females for
selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard World Population).




















The incidence of mouth cancer in males is high in many parts of Asia (Figure l4a).
As with tongue cancer, India is again the focus with many regions reporting rates
exceeding 6.0 per 100,000 per annum, peaking with Trivandrum registry in Southern












Figure 14a. Asia. Incidence of mouth cancer (143-5 ICD-9) in males for selected
regions of Asia. Average annual age-standardised rates per 100,000 population
(Standard World Population).














In a study from Bombay from 7918-1982, Hamada et al (199I) found that mouth
cancer made up 33.5Vo of all cancers of the mouth and pharynx (140-149 ICD-9) and
43.OVo of all intraoral cancer in males. Paralleling tongue cancer ttends, mouth cancer
is common among the Indian sub-population of Singapore. Once again, tobacco and
betel habits are implicated as the primary aetiological agents for the consistently high
rates seen in India (Sankaranarayanan 7990a; Daftary et al I99I), but
Sankaranarayanan et al (1989) suggested that other factors may be involved in the
development of oral cancer in patients under 30 years of age. Both Jayant and Yeole
(1987) and Coleman et al (1993) have reported a plateauing in mouth cancer
incidence in India from the 1960's to the mid-1980's, but rates remain amongst the
highest in the world.
In contrast to India, the risk of mouth cancer in Japan is low, but the rate has risen
dramatically. The incidence rate for mouth cancer in Osaga between 1970-1971 was
0.2per 100,000 per annum (Waterhouse et al 7916), while from 1983-1981 it had
risen to 1.6 per 100,000 per annum (Parkin et al 7992). Similar trends are seen
elsewhere in Japan. This trend is confirmed by two recent studies into oral cancer
mortality in Japanese males. Both Zheng et al (1999) and Su et al (1999) found a
significant rise in mouth cancer mofiality, particularly cancer of the floor of the
mouth, between 1950-1993 and 1950-1994 respectively.
Higher rates of mouth cancer are also reported for Manila (3.1) and Chiang Mai (2.6),
but according to Reichardt (1995), both incidence and mortality rates for oral cancer
in Thailand are decreasing. Reichardt proposed that this was primarily due to a fall in
I
the prevalence of betel chewing in the population.
71
b. Female
The incidence of mouth cancer in females is high in parts of Asia (Figure 14b), and in
some regions exceeds the corresponding male rate. These areas included The
Philippines, Thailand and parts of India (Bangalore and Madras). A more detailed
subsite analysis using four digit rubrics from the latest edition of Cancer Incidence in
Five Continents (Parkin et al 1991) revealed the majority of these cases occurred at













Figure 14b. Asia. Incidence of mouth cancer (143-5ICD-9) in females for selected
regions of Asia. Average annual age-standardised rates per 100,000 population
(Standard World Population).








Hamada et at (1991), in their study of oral cancer in Bombay between 7978-7982,
found that mouth cancer made up 53.2Vo of all cancers of the mouth and pharynx
(140-149ICD-9) and 67.8Vo of all intraoral cancer (741,143-145 ICD-9) in females.
Cancer primarily originating in the soft palate is uncommon, but this unusual form of
mouth cancer is seen in some areas of Asia. In areas where reverse smoking is
practised, ít comprises between 38-487o of all oral cancer (Daftary et al 1997). In
contrast to other forms of intraoral cancer, palatal cancer resulting from reverse
smoking is more common in women. The changes to palatal mucosa caused by this




The incidence of mouth cancer in males in Oceania (Figure 15a) is relatively low in
global terms. In Australia, only Western Australia (2.6) and New South Wales (2.9)
report rates higher than 2.5 per 100,000 per annum, while the New Zealand rate for





Figure 15a. Oceania. Incidence of mouth cancer (143-5 ICD-9) in white males for
selected regions of Oceania. Average annual age-standardised rates per 100,000
population (Standard World Population).
Source: Parkin et al, Cancer Incidence in Five Continents, Volume VII (1997).
The curent South Australian rate of 2.5 per 100,000 per annum is slightly higher than
the 1.9 per 100,000 per annum reported by Roder and Wilson (1983) between 1911-
1980. Macfarlane et al (7994) demonstrated considerable geographic variation in
80
incidence rates for intraoral cancer (including tongue) within the Sydney metropolitan
area between 1972-90. While the overall incidence rate for intraoral cancer in New
South Wales was 5.4 per 100,000 per annum, these authors found an incidence of 16.0
per 100,000 per annum in Sydney City.
The latest rate of 3.6 per 100,000 per annum among the male Maori population people
of New Zealand is considerably higher than the previously reported 1.5 per 100,000
per annum from 1983-1987 (Parkin et al 1992).In Australia, mouth cancer rates seem
relatively stable, although Coleman et al (7993) reported a slight increase from 1973-
1981. Cox et al (1995), however, reported significant upward trends for both the
incidence and mortality of mouth cancer in New Zealand between 1955-1991.
While it is generally known that intraoral cancer rates are high in other parts of
Oceania, particularly Papua New Guinea (Henderson & Aiken 1919; Manin et al
1992) and the islands of Melanesia (Taylor et al 1983), little reliable population-based
data for mouth cancer incidence have been published for these regions. An interesting
observation, however, is the exceptionally high incidence of mouth cancer reported in
Pacific Polynesian islanders between 7918-1982 (Muir et al 1987). This incidence
rate of 10.2 per 100,000 per annum does not seem to have been further investigated.
The number of cases and likely accuracy of this data is uncertain and it is also noted
that the report does not record arate for tongue cancer in this population group, which
may indicate that this figure combines tongue and mouth rates. The latest data (Parkin
et at 7997) revealed elevated rates for both tongue (3.3) and mouth (4.5) cancer in




The incidence of mouth cancer in females in Oceania (Figure l5b) is low with no
registries reporting rates greater than 1.5 per 100,000 per annum. All regions report





Figure 15b. Oceania. Incidence of mouth cancer (143-5ICD-9) in white females for
selected regions of Oceania. Average annual age-standardised rates per 100,000
population (Standard World Population).
Soutce: Parkin et al,Cancer Incidence in Five Continents, Volume VII (1997).
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2.3.3.4 Salivary Gland Cancer 142 (lCD'g)
Salivary gland tumours are a unique and variable group of lesions that have provided
much confusion in both diagnosis and management over many years. In most
populations they occur less frequently than other oral cancers and are most often seen
in the parotid gland. The aetiology and behaviour of salivary gland tumours is
completely different from other oral cancers, a point noted by many authors and an
important reason for classifying these lesions separately from other oral cancers.
Pindborg (1917) regrets the modification in the ninth revision of the International
Classification of Diseases, whereby tumours occurring in minor salivary glands were
removed from the category of "salivary gland tumours" (142ICD-9) and classified
according to subsite. In his opinion, this change means, "future studies on oral cancer
epidemiology will suffer." While the majority of malignant salivary gland tumours
fall under the broad category of adenocarcinomas, the latest WHO classification
(WHO 1990; Seifert 1991) lists eighteen distinct carcinomas of salivary glands. There
is, however, no uniformity in the literature as to the exact nature and behaviour of
these different tumours and the precise pathologic classification of salivary gland
cancer remains a continuing problem. This review focuses on the broad category of
salivary gland carcinomas of the major glands (142 ICD-9), with no attempt to
subdivide this complex group of tumours further.
Apart from Europe and North America, the literature contains limited data on the
epidemiology of salivary gland tumours (Ostman et al 1997). The attached maps
(Figures 16-20) summarise data from the 7th edition of Cancer Incidence in Five




In North America (Figure 16a) the incidence of salivary gland cancer is low with few










Figure 16a. North America. Incidence of salivary gland cance (l42ICD-9) in white
males for selected regions of North America. Average annual age-standardised rates
per 100,000 population (Standard World Population).























The highest incidence rate in Canada (and one of the highest in the world) is reported
in the Northwest Territories (4.2), although it should be noted that this rate is based on
a relatively small number of cases. The high rate in the northem regions of Canada
has been noted in earlier editions of Cancer Incidence in Five Continents (Parkin et al
1992) and may be linked to previously reported cases of highly malignant
lymphoepithelial adenocarcinomas observed in Alaskan natives in the 1960's and
1970's (Blot et al 1915; Lanier et al 19'76). This poorly differentiated tumour was
commonly seen in the parotid gland and resulted in significantly increased mortality
rates among the natives of Alaska. Merrick et al (1986) in a study of on salivary gland
carcinoma in Greenland, reported an incidence rate in males of 3.9 per 100,000 per
annum between 1965-1974. No subsequent data for this region were found.
The United States SEER rate for salivary gland tumours in males is 1.0 per 100,000
per annum, with only a few centres reporting rates higher than this figure. Muir and
Weiland (1995), in an extensive review of upper aerodigestive tract cancers, reported
a complex picture. These investigators found that some types of salivary gland
tumours are increasing, while others are decreasing. Devesa et al (1995) reported an
overall decrease in mortality from salivary gland tumours in the United States from
1915-1991, although incidence rates were stable. In a more specific study of data
from the San Francisco-Oakland registry between 1973-1988, Hom-Ross et al (1991)
found a sudden and sustained doubling in the incidence of salivary gland cancer




The incidence of salivary gland tumours in the female populations of North America
(Figure 16b) is quite variable, although all regions report incidence rates lower than
the corresponding male rates. As with the male rate, the Northwest Territories of
Canada reports the highest incidence, but this rate of 2.O per 100,000 per annum is
based on a small number of cases. Merrick et al (1986) reported a female incidence
rare of 7.7 per 100,000 per annum in Greenland between 1965-1974. At this time, this
was approximately double the male rate and the authors commented that "it is well
known that the incidence of SGC (Salivary Gland Carcinoma) in Eskimos is twice as
high in women as in men both in Alaska and in Greenland."
The incidence of salivary gland tumours among females in the United States is low





















Figure 16b. North America. Incidence of salivary gland cancer (142ICD-9) in white
females for selected regions of North America. Average annual age-standardised rates
per 100,000 population (Standard World Population).







The incidence of salivary gland cancer in South American males (Figure 17a) is low
with few regions reporting rates over 1.0 per 100,000 per annum. Cali, Columbia,
reported a higher incidence rate of 2.1 per 100,000 per annum for salivary gland
cancer during the 1960's (Doll er at 7966), but this has not been repeated recently'
Figure 17a. South America. Incidence of salivary gland cancer (142ICD-9) in white
males for selected regions of South America. Average annual age-standardised rates
per 100,000 population (Standard V/orld Population)'
Source: Parkin et al, Cancer Incidence in Five Continents, Volume VII (1997).
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b. Female
The incidence of salivary gland tumours in females in South America (Figure 17b) is
low, but it is interesting to observe that in some regions female rates are the same as
the corresponding male rates, while in Trujillo, Peru, the incidence is greater.
Figure 17b. South America. Incidence of salivary gland cancer (l42ICD-9) in white
females for selected regions of South America. Average annual age-standardised rates
per 100,000 population (Standard World Population).




The incidence of salivary gland cancer in males in Europe (Figure l8a) is generally
low with only Southern Ireland (1.2) and some regions of Italy reporting rates greater










Figure 18a. Europe. Incidence of salivary gland cancer (l42ICD-9) in white males
for selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard V/orld Population).











Although some regions of France have reported consistently high rates since the late
1970's, the latest data confirms that the incidence appears to be stable or decreasing'
This trend is supported by data for cancer mortality in France between 1950-1985
(Hlll et al l99I) which showed only minor changes in mortality from salivary gland
tumours. It is interesting to observe that in 1978 the urban incidence rate in the Doubs
region was 3.5 per 100,000 per annum while the rural rate was only 1.3 per 100,000
per annum, giving an overall incidence of 2.1 per 100,000 per annum (Waterhouse et
at 1982). Between L978-1982 (Muir et al 1987), however, the overall incidence had
fallen to 1.6 per 100,000 per annum, due mainly to a significant drop in the urban rate
(1.5) that masked a rise in the rural rate (1.9).
In an extensive study of malignant salivary gland tumours in Sweden over the past 30
years, Ostman et al (7997) reported a relatively stable overall incidence rate in males,
while noting variations in specific glands/subsites. Another interesting observation
comes from Scotland between 1983-1987 (Parkin et al 1992) where the overall rate of
0.8 per 100,000 per annum masks a much higher incidence of 2.2 per 100,000 per
annum in the Northeast region. This is a somewhat unusual finding since previous
dara (Waterhouse et at 1982 }r4tir et al 1981) demonstrated consistently higher rates
in the Southeast region. Elsewhere in the United Kingdom, the incidence of salivary
gland cancer seems low and stable, with Hindle and Nally (1991) reporting a decrease
in the number of cases in England and Wales between 1962-1967 and 1980-1984. A
recent observation (Swerdlow et al 7995a) was an increased risk of salivary gland




The incidence of salivary gland tumours in European females (Figure 18b) is low with
few regions reporting rates greater than 0.5 per 100,000 per annum. The reported
incidence rate in Malta (1.1) is much higher than the corresponding male rate, but it is





Figure 18b. Europe. Incidence of salivary gland cancer (742ICD-9) in white females
for selected regions of Europe. Average annual age-standardised rates per 100,000
population (Standard World Population).













In a detailed study of malignant salivary gland tumours in Sweden between 1960-
1989, Ostman et at (1997) showed that the overall female incidence rates had
remained stable over that time period, with minor variations between different
subsites. Iirill et al (1991) showed that, in France, the mortality from salivary gland
tumours in females had remained stable between 1950-1985.
In England and Wales, Hindle and Nally (1991) demonstrated a drop of almost 50%











In Asia the rate of salivary gland cancer in males (Figure 19a) is low with only Korea
(1.6) and Manila (1.2) reporting an incidence rate greater than 1.0 per 100,000 per
annum. The elevated Korean figure is based on a small number of cases. The rates in









Figure 19a. Asia. Incidence of salivary gland cancer (142 ICD-9) in males for
selected regions of Asia. Average annual age-standardised rates per 100,000
population (Standard World Population).

















Su et al (1999) reported an increase in age-adjusted mortality of salivary gland cancer
in Japanese males from 1950-1994, but this trend appears to have plateaued since
1980.
b. Female
The incidence of salivary gland tumours in Asian females (Figure 19b) shows a
variable pattern. In some regions rates are higher than the corresponding male rates,
but generally they are less. The elevated rate reported for the Indian female population
















Figure 19b. Asia. Incidence of salivary gland cancer (142 ICD-9) in females for
selected regions of Asia. Average annual age-standardised rates per 100,000
population (Standard World Population).











The incidence of salivary gland cancer in males in Oceania (Figure 20a) shows an
incidence rate range from 0.4 per 100,000 per annum in Tasmania to 1 .2 per 100,000





Figure 20a. Oceania. Incidence of salivary gland cancer (l42ICD-9) in white males
for selected regions of Oceania. Average annual age-standardised rates per 100,000
population (Standard World Population).
Source: Parkin et al, Cancq Incidence in Five Continents, Volume VII (1997)'
The South Australian situation is interesting with a higher rate of 1.5 per 100,000 per
annum reported both in 7977 (Waterhouse et al 1982) and between 1978-1982 (Muir
et at 1981). Roder and Wilson (1933) also reported an elevated rate of 1.7 per 100,000






This study examined the principal oral cancer sites using the classification outlined in
The International Classification of Diseases, Ninth Edition (WHO 1911) namely:
Lip 140,173.0
Tongue 147
Major Salivary Glands I42
Gum 143
Floor of mouth 144
Mouth, other parts 145
The raw data for each site were analysed using Excel "(Microsoft) software for
distribution by sex and age at diagnosis. Simultaneously all cases were also analysed
by pathological type or morphology using the coding from The International
Classification of Diseases for Oncology, Second Edition (WHO 1990). These findings
are presented in both tabular and graphical form.
Following guidelines recommended by the Intemational Agency for Cancer Research
(IACR) (Esteve et al 1994), age-specific and age-standardised (world standard
population) incidence and mortality rates were also calculated. A worked example of
the calculation of population-based incidence rates for lip cancer in 1996 is presented
in Table 5.
t02
Poisson regression analyses were carried out for each site to assess time trends in
incidence and mortality rates during the period 1977-1996. The predictor values used
in these multivariate analyses were calendar year of diagnosis or death as appropriate
and corresponding age expressed in five-year categories. An example of this
calculation for lip cancer incidence in South Australian males between 7977-1996 is
presented as Appendix IV.
Excel 'M(Microsoft) software was used to construct graphs of the various parameters
for each site. Excel rM(Microsoþ - generated logarithmic trendlines were added to the





4.1 Oral Cancer 140-5 (ICD-9)
A total of 4054 cases of oral cancer (140-5 ICD-9) were reported to the South
Australian Cancer Registry between I9l1-1996. The raw data relating to these cases
are summarised in Tables 6-8.
Table 6 is a summary of the raw data by site (ICD-9) and sex. It shows that72.9Vo oÏ
all cancers occurred in males with 21.7c/o found in females. The lip was the most
common site of occurrence (61.O7o) with the vast majority of these lesions (12.57o)
occuning on the lower lip (ICD-9 140.1) (See Table 11).
Tables I and 8 present the tumour pathology/morphology for these lesions by sex and
site respectively, using the ICD-10 classification coding. Squamous cell carcinoma
was the dominant form of malignancy accounting for 8l.5%o of all oral cancer in
South Australia between 1971-1996. If all cases of salivary gland cancer are removed
from the data, this figure rises to 93.5Vo.
The average age at diagnosis for oral cancer in South Australia between 1977-1996
was 59.3 years in males and 66.0 years in females. The age distribution at diagnosis















122164145 Malignant neoplasm of other and unspecified parts of mouth
22660r66144.9 Floor of mouth, part unspecified
226
(5.6Vo\






3139143 Malignant neoplasm of gum
r86t2142.9 Salivary gland, unspecified






tt2190142 Malignant neoplasm of major salivary glands
24r82159141.9 Tonsue. unspecified
22t2l0I4l.3Yenîal surface of tongue
1134t72I4l.2Tip and lateral border of tongue
8J5141.1 Do¡sal surface oftongue
lo1456141.0 Base of tongue
454
(ll.2Vo\
152302141 Malignant neoplasm of the tongue
22115r54173.0 Skin of lip
30974235140.9 Lip, unspecified
t9703tz1598140.1 Lower lip, vermilion border
2t0702108140.0 Upper lip, vermilion border
2716
(67.UVo)
62120951401173,0 Malignant neoplasm of the lip
TOTALFernaleMaleSITE







M912-M916 Blood vessel tumours
1190t013
M906-M909 Germ cell neoplasms
ICarcinosalcoma, NOS8980/3
))1111Mixed tumour. malisnant894013






M880 Soft tissue tumours and sarcomas NOS
)
1IAdenosouamous carcinoma8560/3
M856-858 Complex epithelial neoplasms
372t16Acinar cell carcinoma8550/3
M855 Acinar cell neoolasms
I38500/3




M844-M849 Cvstic, mucinous and serous neoplasms
812457Mucoepidermoid carcinoma843013
M843 Mucoeoidenmoid neoolasms
IIPaoillarv carcinoma, papillary variant834013
I832313
23Clear cell adenocarcinoma, NOS83 10/3
-t3Oxyphitic adenocalcinoma829013





482622Adenoid cvstic carcinoma, NOS820013
43t825Adenocarcinoma. NOS8 1 40/3
M8f4-M838 Adenomas and adenocarcinomas
.JI2Tlansitional cell carcinoma8t2313
M812-M813 Transitional cell papillomas and carcinomas
2IBasosquamous carcinoma809413
M809-M8Il Basal cell neoplasms
13836t02LvmDhoeDithelial carcinoma8082/3
55Souamous cell carcinoma, microinvasive8076/3
I,|
1Scuamous cell carcinoma, spindle cell8074t3
1046Scluamous cell carcinoma, kelatinising, NOS80'7U3
35499052644Souamous cell carcinoma, NOS8070/3
I1Paoillary squamous cell carcinoma805213
l477Verrucous carcinoma80s I /3
M805-M808 Squamous cell neoplasms




11Calcinoma. NOS80 1 0/3




Table 7. Oral Cancer in South Australia, 1911-1996: Raw data - tumour morphology/






M9l2-M916 Blood vessel tumours
II907013
M906-M909 Germ cell neoÞlasms
ICarcinosarcoma NOS8980/3
22ztIMixed tumour, malignant8940t3






M880 Soft tissue tumours and sarcomas NOS
22Adenosrrrr¡r¡ous carcinonra8560/j
M856-858 Complex epithelial neoplasms
37334Acin¡r cell carcinorna85s0/3
M855 Acinar cell neoplasms
-3?R5(Y)/1




M844-M849 Cvstic. mucinous and serous neoplasms
8t6516Mucoepidermoid carcinonla843013
M843 Mucoeoidermoid neoDlasms
IPaoillary carcinorna. papillarv variant8340t3
It832313







48i3t4IAdenoìd cvstic carcinorr¡- NOS820013
43)c)t3Adenocarcinoma. NOS814013
M8f4-M838 Adenomas and âdenocarcinomas
33Transìtional cell carcinoma8t2313
M8f2-M813 Transitional cell DaDillomas and carcinomas
33Bâsôsûrâmôlrs carcinom¡809413
M809-M811 Basal cell neoÞlâsms
t3ßt5474234Lymphoepithelial crcinoma8082/3
I4Squamous cell c:trcinoma, microinvrsrve8076/3
2ISouamous ceìì ca¡cinoma. spindle cell8014t3
l03I6Squamous cell carcinoma. keratinising. NOS807l/3
3549424s23942661Squamous cell c¡Ùcinona. NOS8070/3
IIPaoilla¡v scuamous cell carci norna805213
t4llt2Venucous cmcinoma80s r /3
M805-M808 Squamous cell neoDlâsms
64IISmall cell carcinoma. NOS8041t3
6-5Itìo30/3
23t813I Ind¡f tèrentiated carcinonra- NOSRO)Oti
IIC¡rcinoma NOS8010/3




Table 8. Oral Cancer in South Australia, l9l7-1996: Raw data - tumour morphology/
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Figure 21. O¡al cancer in South Australia, 1977-1996 : Age at Diagnosis (Tabulated data shows actual number of cases).
4.I.1 Oral Cancer Incidence
Incidence trends for oral cancer in South Australia between 1977-1996 are presented
in Figures 22-24. Figure 22 provides crude and age-standardised rates for both males
and females. Both males and females show a significant increase in oral cancer
incidence as subject age rises (P<0.0001). While there is an upward trend in oral
cancer incidence in males between 1971-1996, this was not significant (P=0.2744). II
females, however, there was a significant increase in oral cancer incidence over the 20
year period (P<0.0001). The rate in 1911 was 1.86 per 100,000 per annum while in
1996 it had risen to I .26 per 100,000 per annum.
Figures 23 and 24 present age-standardised incidence rates for oral cancer by site for
males and females respectively.








Table 9. Oral Cancer in South Australia, 7911-1996: MaleÆemale incidence ratios
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(, Figure 24. O¡al cancer 
incidence in South Australian females, 1977-1996: Site trends (taoutæeo data - ageetandardised rates per lo0,ü!0 per annum)
4.I.2 Oral Cancer Mortality
The number of deaths from oral cancer in South Australia between 1917 -1996 is














Table 10. Oral Cancer Mortality in South Australia, 1971-1996: Raw data - site and
sex distribution
Mortality trends for oral cancer in South Australia between 1911-1996 are presented
in Figures 25-27. Figure 25 gives crude and age-standardised mortality rates for both
males and females. The mortality rate for oral cancer in males has remained stable
between 1911-1996. An increase was observed in females, but this was not
statistically significant.
Figures 26 and27 present age-standardised mortality rates for oral cancer by site for
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Figure 27. Oral cancer mortality in South Australian females, 1977-1996 : Site trends (tabutateo data - age-standardised rates per lo0,00o perannum)
4.2 Lip Cancer 140 (ICD-9)
Figures 28-30 present the data for lip cancer (140 ICD-9) incidence and mortality in
South Australia between 1977 -1996.
The lip was the most common site f'or oral cancer (Table 6) comprising 67.OVo of all
cases. The lower lip (140.1 ICD-9) was the most common subsite accounting for
72.5Vo of cases. This was followed by lip unspecified (140.9 ICD-9) 17.4Vo, skin of
lip (173.0 ICD-9) 8.4Vo and upper lip (140.0 ICD-9) 1.77o. Almost all reported
malignancies of the lip (98.O7o) were squamous cell carcinoma (See Table 8).
The average age of diagnosis for lip cancer was 58.3 years in males and 66.0 years in
females. Figure 28 shows the age distribution at diagnosis for lip cancer. Regression
analysis showed a highly significant association between lip cancer incidence and
increasing patient age for both sexes (P<0.0001).
Figure 29 presents the crude and age-standardised ìncidence rates for lip cancer rn
South Australia between 1911-1996. The male rate showed a significant increase over
the 20 year period (P=0.0004), although it appears to have plateaued somewhat in the
past decade. In contrast, the female rate has increased significantly since 7977
(P<0.0001) and continues to rise at a steady rate.
Mortality from lip cancer in South Australia between l97l-1996 was low and this is
reflected in the mortality rates presented as Figure 30. Although the incidence of lip
cancer increased over the 20 year period, there were no significant changes in the
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Figure 30. Lip cancer in South Australia, 1977-1996 : ilortality trends (talulateo data præents crude and agectandardised rates per 100,0fi) per annum)
4.3 Tongue Cancer 141 (ICD-9)
Figures 3l-33 present the data for tongue cancer (141 ICD-9) incidence and mortality
in South Australia between 1971-1996.
The tongue was the most common intraoral site for oral cancer (Table 6) comprising
17.27o of all cases and 43.8Vo of intraoral malignancies. The tongue unspecified
(14I.9 ICD-9) was the most commonly reported subsite accounting Tor 53.1Vo of
cases. This was followed by tip and lateral border of tongue (141.2ICD-9) 24.97o,
base of tongue (141.0 ICD-9) 75.4Vo, ventral surface of tongue (l4l.3ICD-9) 4.87o
and dorsal surface of tongue (l4l.l ICD-9) 7.8Vo. While most repofted cases of
tongue cancer were squamous cell carcinoma (86.8Vo), there were also a number of
cases of lymphoepithelial carcinoma (9.37o) reported at this site (See Table 8).
The average age of diagnosis for tongue cancer was 62.2 years in males and 65.5
years in females. Figure 31 shows the age distribution at diagnosis for tongue cancer.
Regression analysis showed a highly significant association between tongue cancer
incidence and increasing patient age for both sexes (P<0.0001).
The crude and age-standardised incidence rates for tongue cancer in South Australia
between 7911 -1996 are presented in Figure 32. The rate for males has remained stable
over the 20 year period (P=0.1182). The female rate did not change significantly
between 1917-1996 (P=0.2345). Mortality rates from tongue cancer in South
Australia between 1911-1996 are presented as Figure 33. There \ilere no significant
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S Figure 33. Tongue cancer in South Aust¡alia, 1977-1996 : Mortality trends (taulated data presents crude and age-standardi.sed rates per l(X),ü)O per annum)
4.4 Mouth Cancer 143-5 (ICD-9)
Figures 34-36 present the data for mouth cancer (143-5 ICD-9) incidence and
mortality in South Australia between 1971-1996. Separate data for specific sites are
presented as 4.4.1.
Malignancies of the mouth accounted Tor 14.47o of all oral cancers (Table 6). Of these
cases, 49.7Vo occurred in other and unspecified parts of the mouth (145 ICD-9),
38.8Vo on the floor of the mouth (I44ICD-9) and l2.0Vo on the gum (143 ICD-9).
The majority of cases of mouth cancer were squamous cell carcinomas (ll.l7o)
although a number of lymphoepithelial carcinomas (8.lVo) were also reported, as were
some cases of salivary gland malignancy (mucoepidermoid carcinoma 2.J7o, adenoid
cystic carcinoma 2.4Vo and adenocarcinoma NOS 2.27o) (See Table 8).
The average age of diagnosis for mouth cancer was 61.4 years in males and 66.7 yeats
in females. Figure 34 shows the age distribution at diagnosis for tongue cancer.
Regression analysis showed highly significant association between mouth cancer
incidence and increasing patient age for both sexes (P<0.0001).
The crude and age-standardised incidence rates for mouth cancer in South Australia
between 191l-1996 are presented in Figure 35. The male incidence rate remained
stable over the 20 year period (P=0.2425). The female rate did not change
significantly between 19ll-1996 (P=0.6756). Mortality rates from mouth cancer in
South Australia between 1971-1996 are presented as Figure 36. There were no
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Figure 36. ilouth cancer in South Australia, 1 977-1996 : Mortality trends (taoulateo data presents crude and age-standardised rates per lü1,000 per annum)
4.4.I Gum, Floor of Mouth and Other Mouth Cancer
Figures 37-42 present incidence data for gum cancer (143 ICD-9), floor of mouth
cancer (l44ICD-9) and other mouth cancer (145 ICD-9) respectively. Mortality data
were not analysed for these sites due to the small number of cases (See Table 10).
The average age at diagnosis for gum cancer was 66.7 years in males and73.9 years
in females. The average age at diagnosis for floor of mouth cancer was 61.3 years in
males and 68.7 years in females. The average age at diagnosis for other mouth cancer
was 60.2 in males and 61.9 years in females. Corresponding to the data for overall
mouth cancer, there were no significant trends observed in incidence rates for these
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ü Figure 40. Floor of mouth cancer in South Australia, 1977è
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õ Figure 42. Other mouth cancer in South Australia, 1977-1996 : Incidence trends (tabutateo data - crude and age-standardised data per 1(X¡,O(X) per annum)
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4.5 Salivary Gland Cancer 142 (lCD-g)
Figures 43-45 present the data for salivary gland cancer (142 ICD-9) incidence and
mortality in South Australia between 1971-1996.
Malignancies of the major salivary glands accounted for'7 .47o of all oral cancers (See
Table 6). The most common site for salivary gland cancer was the parotid gland
(142.0ICD-9) J8.87o, followed by the submandibular gland (142.1 ICD-9) 73.27o,
unspecified gland (142.9ICD-9) 6.OVo, other major glands (overlapping sites) (142.8
ICD-9) l.3%o, and the sublingual gland (142.2 ICD-9) 0.17o. Of the various
malignancies repofted, mucoepidermoid carcinoma (2I.57o), squamous cell
carcinoma (l3.9Vo), adenoid cystic carcinoma (1O.2Vo), acinar/acinic cell carcinoma
(l0.2%o), adenocarcinoma NOS (9.67o), and malignant mixed tumour (1.07o) were the
main morphological types (See Table 8).
The average age of diagnosis for salivary gland cancer was 61.4 years in males and
61.9 years in females. Figule 43 shows the distribution of age at diagnosis for salivary
gland cancer. Regression analysis showed highly significant association between
salivary gland cancer incidence and increasing patient age for both sexes (P<0.0001).
The crude and age-standardised incidence rates for salivary gland cancer in South
Australia between 1971-1996 are presented as Figure 44.The rate for males remained
stable over the 20 year period (P=0.1931). The female rate did not change
significantly between 1911-1996 (P=0.4869). Mortality rates for salivary gland cancer
in South Australia between 1977-1996 are presented as Figure 45. There were no
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Oral cancer is a disease involving the tissues of the lips and oral cavity. The patterns
of global epidemiolo Ey are far from uniform and the trends in oral cancer in South
Australia over the past 20 years are also quite unique.
A number of researchers (Boyle et al 1990, Jovanovic et al 1993a, Morse et al 1998,
Sankaranarayanan 7990a, Smith 1919) have highlighted the terminology dilemma
concerning "oral cancer". There is no standardised terminology or definition for oral
cancer in the literature and there are even instances where the same author has used a
different term or definition in different papers (See Table 2). As a consequence,
comparisons of individual studies must be carried out with some degree of caution.
The revised coding system in the l0tr' edition of the International Classification of
Diseases (ICD-10) (WHO 1992), attempts to address this problem, but it appears that
most researchers are not willing to apply this system in their publications. For
example, the latest edition of Cancer Incidence in Five Continents (Parkin et al 7997)
still uses the coding from the 9th Edition Internationat Ctassification of Diseases
(ICD-9) (WHO 19ll). Reviewing both the global incidence and monality trends and
the situation in South Australia over the past 20 years, a reasonable classification for
"oral cancer" may be to group it into the following subgroups:
Lip - 140 (ICD-9); C00 (ICD-10)
Inrraoral or Buccal cavity - 747,143-145 (ICD-g); C01-C06 (ICD-10)






The cancers in these broader groups seem to have similar biological and
epidemiological characteristics. It is felt that the tetm "intraoral cancer" is a better
description than "mouth cancer", which usually refers to intraoral sites excluding the
tongue. Although some authors have suggested this or a similar classification (Chen er
al 1992; Johnson and Warnakulasuriya 1993; Moreno Lopez and Esparza Gomez
1998; Morse et al 1999), the vast majority of studies continue to group oral and
pharyngeal cancers together. V/hile combining all sites may decrease the problems of
mapping large lesions and identifying a primary site in overlapping lesions, as well as
increasing the number of cases for study in the broader diagnostic category, it does
result in the loss of much information of cancers in the individual sites (Smith 1989; ,
Muir and Staszewski 1991 ; Oreg gia 1991; Chen et al 1992; Morse et al 1999). This is
clearly demonstrated in the South Australian data where lip cancer is the dominant
form of "oral cancer".
In this study, it was decided to use the existing coding system of the South Australian
Cancer Registry (i.e. ICD-9), rather than attempting to update the data to the later
coding (i.e. ICD-10). It is recognised that this may only serve to propagate the
problem, but particular emphasis is given to the trends in individual sites rather than
to "oral cancer" as a whole.
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5.2 Oral Cancer 140-5 (ICD-9)
The trends in incidence and mortality for oral cancer (140-5 ICD-9) over the period
191l-1996 are interesting. The fact that squamous cell carcinoma is the dominant
histological type (See Table 7) conforms to well established worldwide trends (Smith
1979, Walton et at I99l; Daftary et al 1992; Muir and Weiland 1995). The general
global trend that it occurs more commonly in males and increases with age (Pindborg
1911; Smith 1989; Johnson 1991; Chen et al 7992; Daftary et al 1992; Johnson &
Warnakulasuriya 1993) are also clearly evident in the South Australian data (Figures
27 and 22). What is of interest, however, is the dominance of lip cancer in South
Australian oral cancer for both males and females. This high incidence of lip cancer in
South Australia completely obscures the fact that intraoral and salivary gland cancer
incidence are quite low. An inverse relationship between the incidence of extraoral
(i.e. lip) and intraoral forms of oral cancer is clearly demonstrated by the South
Australian data. Figures 23 and 24 show how the age-standardised oral cancer
incidence rate basically follows the lip cancer trend in both males and females. The
male/female incidence ratio fell from 4.41 between 79ll-7981 to 2.98 between 1992-
1996 (See Table 9). Once again this principally reflects a fall in the corresponding lip
cancer ratios over the 20 year period. This finding provides further strong evidence
for the importance of separating the lip from other intraoral cancer sites in any oral
cancer studies (Chen et al 7992, Morse et a|7999).
The mortality rates for oral cancer in South Australia are less dramatic. It is well
recognised that lip cancer has a high survival rate (Antoniades et al 1995, Gerson
1990, Muir & Weiland 1995), and this means that although incidence rates are high,
the mortality from oral cancer in South Australia between 1917-1996 was quite low
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and stable (Figures 25-27). This contrasts to reports from a number of European
countries, particularly Eastern Europe (HlIl et al 1991.; La Vecchia et al 1992;
Macfarlane et al 1994a. Plesko et al 7994; La Vecchia et al l99l) and Japan (Su et al
1999, Zheng et al 1999), where mortality rates from oral cancer are increasing,
particularly amongst males.
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5.3 Lip Cancer I4O (ICD-9)
The incidence of lip cancer (140 ICD-9) in South Australia over the period 1917 -1996
is the most significant and plzzling finding of this study. As previously discussed,
cancer of the lip dominates all other oral cancer sites in South Australia. One
important point about the South Australian lip cancer data, however, is that it includes
lesions reported on the skin of the lip (173.0 ICD-9). This practice, which has
occurred since the establishment of the South Australian Cancer Registry, was
apparently instituted in order to eliminate a potential problem of under-reporting of lip
cancer cases. It is believed that malignancies that begin on the vermilion but spread to
the dermis may be incorrectly classified as skin cancer and therefore not included in
the oral cancer data (See Appendix I). It must be pointed out, however, that this
subsite accounts Tor 8.47o of all cases of lip cancer reported between 1911-1996,
which tends to elevate the South Australian figures, compared to other registries that
do not include this subsite. Perhaps the definition of Ebenius lrom 7943 should not be
forgotten : "No other cancer than that arising in the red of the lip should be regarded
as genuine lip cancer" (Morton et a|7983),
It is well recognised that the lower lip is by far the most common site for lip cancer
(Chen et al1992; Daftary et aI1992: Antoniades et al1995; Ostman et a|7995; Faye-
Lund & Abdelnoor 1996; de Visscher et al 1998; Morse et al 1999). This trend is
supported by the South Australian data (See Table 6), with almost l57o of lesions
occurring at this site. This observation, combined with the fact that lip cancer tends to
occur far more commonly in men employed in outdoor activities (i.e. fishermen,
farmers and labourers), has led to the suggestion that sunlight is the key aetiologic
agent in its pathogenesis (Lindqvist & Teppo 1978; Lindqvist et al 1981; Douglass &
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Gammon 1984; Brownson ¿t al 1989; Pukkala et al 1994; Antoniades et al 1995;
Pukkala and Notkola 1991; Acquavella et al 1998). The South Australian data
provided no information about patient's occupation, so this trend could not be
confirmed.
Many researchers have observed that lip cancer occurs more commonly in elderly
males (Chen et al 1992; Abdelnoor et al 1995; Ostman et al 7995; de Visscher et al
1998; Morse et al 1999). The South Australian data supports this trend with 7'7.l%o of
cases seen in males and the average age at diagnosis being 58.3 years (Figure 28). In
females, the average age at diagnosis was 66.0 years. A highly significant association
between lip cancer incidence and increasing age was found in both sexes. It is
interesting to note, however, that when cancer of the upper lip (140.0 ICD-9) is
analysed separately, the gender discrepancy almost disappears (Males 108 cases,
Females 102 cases). As a consequence, while upper lip accounts for only 5.2Vo of Íp
cancer cases in males, it comprises l6.4Vo of lip cancers in females. This trend has
been noted in other regions including Connecticut (Chen et al 1992; Morse et al
7999), the Netherlands (de Visscher et al 1998), and Sweden (Ostman et al 1995).
Almost 20 years ago, Lindqvist and Teppo (1980) proposed that upper lip cancer
should be considered as a completely distinct type of cancer separate to other lip sites,
and the distinctive epidemiology of this lip cancer subsite in South Australia might
add further support to this suggestion.
It has been noted that lip cancer is relatively rare in dark skinned populations
(Lindqvist 1979; Onuigbo 1978; Binnie & Rankin 1988b; Parkin et al 1992;Parkin et
al 1991; de Visscher & van der Waal 1998), a trend that has been explained by the
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protective effects of natural skin pigments against the carcinogenic action of solar
radiation (Douglas & Gammon 1984). Unfortunately no data were available for lip
cancer incidence in South Australian Aborigines, to allow a similar analysis in this
state between 1911 -7996.
The overall incidence rates for lip cancer in South Australia between 1917 -7996 are
pafiicularly significant (Figure 29). Both male and female rates are amongst the
highest in the world and, contrary to general global trends, they have increased
significantly in the Z}-year period. While the male rate seems to have plateaued in the
past decade, it remains high not only in the Oceania region, but also when considering
other regions known for higher incidence of lip cancer including the Maritime
Provinces of Canada and parts of Europe, particularly Spain. No curent data was
available from Queensland, which had previously reported higher rates of lip cancer
than South Australia (Tan 1970; Muir ¿r al 1981).
The female incidence rate is of particular concern. Not only is it the highest reported
rate for any country in the world (Parkin et al 1991), but contrary to global trends
(Coleman et al 1993; Macfarlane et al 1993; Devesa et al 1995; de Visscher et al
1999; Morse et al 1999), it continues to increase at an alarming rate. Ostman et al
(1995) noted a slight increase in the incidence of lip cancer in females in the
Netherlands between 1960-1989, but this is not nearly as dramatic as the South
Australian trend. More recent data for lip cancer in South Australian females
maintains this high level with an incidence rate of 4.3 per 100,000 per annum being
reported during 1997 (South Australian Cancer Registry 1998) and 5.1 per 100,000
per annum in 1998 (South Australian Cancer Registry 1999). This change is also
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reflected in the maleÆemale incidence ratio for lip cancer which has fallen from 5.32
between 7977-1981 to 3.42 between 7992-1996 (See Table 9). The reason for the
surprisingly high incidence of lip cancer in South Australian females is unclear.
Whether females are being exposed to more of the commonly cited risk factors (i.e.
sunlight, tobacco smoking, and viruses) can only be surmised from this data, but the
fact that lip cancer continues to increase at an alarming rate in South Australian
females remains a major cause of concern.
It is well known that the slow growth rate of lip cancers, the rarity of lymph node
metastases, and the accessibility of the site for complete surgical excision, results in a
low mortality rate (Gerson 1990; Antoniades et al 19951, Muir & Weiland 1995). This
is confirmed in the South Australian data betweenlgll-1996, with only 35 reported
deaths from lip cancer in the 2}-year period (See Table 10). Hence, age-standardised
mortality rates never exceeded 0.5 per 100,000 per annum in either sex (See Figure
30) and for a number of the years, this rate was zero.
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5.3 Tongue Cancer 141 (ICD-9)
Many researchers have found that the tongue (141 ICD-9) is the most common
intraoral site for cancer (Krolls & Hoffman 1976; Mashberg,l989; Chen et al 1990b;
Hamada et al l99l; Hindle & Nally 1991). The South Australian data confirms this
finding with the tongue accounting for 45.0Vo of intraoral cancers in males and 4I.67o
in females. The observation that squamous cell carcinoma was the predominant
histopathological type of lingual malignancy in South Australia, follows the pattern
seen in other regions (Chen et al 1991; Muir & Weiland 1995; Ramirez-Amador et al
1995). It is interesting to note that almost 707o of lingual cancers were
lymphoepithelial. Tongue cancer is a disease of the elderly and the South Australian
data supports this trend with the average age at diagnosis being 62.2 years in males
and 65.5.years in females. There was also a highly significant association between
tongue cancer incidence and increasing patient age in both sexes. Nevertheless, there
were a few cases of tongue cancer (l.3Vo) in patients aged less than 30 years of age.
In comparison to other parts of the world, the incidence of tongue cancer in South
Australians was low, with the age-standardised male rate never exceeding 2.5 per
100,000 per annum and the female rate rarely rising above 1.0 per 100,000 per
annum. The maleÆemale incidence ratio has risen between 1977-1996 (See Table 9),
but it is important to note that there was no significant change in the incidence rates in
either sex over the 2O-year period. This contrasts to findings elsewhere in the world
including parts of the United States (Davis & Severson 1987; Coleman 1993),
England and 'Wales (Hindle & Nally 1991), Scotland (Macfarlane et al 7992),
Denmark (Moller 1989), Finland (Kari et al 1997), Sweden (Ostman et al 1995), and
Japan (Coleman et al 1993). Although the incidence of tongue cancer remains high in
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many parts of the Indian subcontinent, the overall risk has been described as stable or
falling (Coleman et at 1993). A study by Macfarlane et al (1994b) found that the
incidence of tongue cancer in males in New South Wales rose between 1972-7990,
while Cox et al (1995) found a similar trend in both males and females in New
Zealand from I 955- 1997.
Tongue cancer accounted for almost 200 deaths in South Australia over the 20-year
period, i.e. 35.0Vo of all oral cancer deaths and 46.77o of intraoral cancer deaths (See
Table 10). The age-standardised mortality rates were low with the male rate rarely
exceeding 1.0 per 100,000 per annum and the female rate staying below 0.3 per
100,000 per annum for all but one year. These mortality rates remained stable over the
Z}-year period in both sexes. This contrasts with the increasing mortality from tongue
cancer reported for parts of the United States (Depue 1986) and Europe (Macfarlane
et al 1987; Coleman et al1993), particularly France (IJill et al1991).
150
5.5 Mouth Cancer I43-S (ICD-9)
Mouth cancer (143-5ICD-9) (i.e. cancer of the gum, floor of mouth and other mouth)
accounted for 74.4Vo of oral cancer in South Australia between 1977-1996. Following
well reported global trends (Chen et al 1990b; Daftary et al 7992; Muir & Weiland
1995; Ostman et al 1995), squamous cell carcinoma was the dominant form of
malignancy in this location (l7.lVo), although other types of neoplasms including
lymphoepithelial carcinoma (8.7Vo), and various salivary gland malignancies, also
contributed significant numbers of cases (See Table 8). The classification of
malignancies of the minor salivary glands according to site has occurred since the
ninth revision of The International Classffication of Diseases (WHO 1911). As they
only contribute a small number of cases to a site dominated by squamous cell
carcinoma, this combination tends to mask the distinctive epidemiology of minor
salivary gland tumours, a point made strongly over 20 years ago by Pindborg (1911).
Paralleling trends seen in tongue cancer, the other forms of intraoral cancer occurred
more frequently in elderly patients with the average age at diagnosis being 61.4 years
in males and 66.1 years in females. This is confirmed by the highly significant
statistical association between mouth cancer incidence and increasing patient age in
both sexes. It is interesting to note that a small number of cases of mouth cancer
(1.1%o) were reported in patients under 30 years of age. While not providing a
statistically significant trend, the observation of intraoral cancers (tongue and mouth)
occurring in young patients, especially females (10 out of 16 cases), must be
monitored.
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In comparison to other parts of the world, the incidence of mouth cancer in South
Australia between 1917-1996 was low, with the age-standardised male rate rarely
exceeding 2.5 per 100,000 per annum and the female rate rarely rising above 1.5 per
100,000 per annum. Over the 2}-year period the male/female incidence ratio for
mouth cancer fell from 2.96 between 1911-1981 to 1.93 between 1992-1996. This
contrasts with an increasing sex ratio for tongue cancer over the same period (See
Table 9). As with tongue cancer, however, there was no significant change in the
incidence rates of the other forms of intraoral cancer in either sex over the Z}-year
period. This contrasts to findings elsewhere in the world including parts of the United
States (Chen et al 7990; Morse et al 1999), England and Wales (Hindle et al 7996),
Scotland (Macfarlane et al 1992), Denmark (Moller 1989), Sweden (Ostman et al
1995), Hungary (Coleman et al 1993), and Japan (Coleman et al 1993). Like tongue
cancer, the incidence of mouth cancer remains high in many parts of the Indian
subcontinent, although the overall risk has been described as stable or falling
(Coleman et al 1993). Gupta and Nandakumar (1999) reported that, since 7982, the
incidence rates for cancer of the oral cavity (all sites) have not shown any significant
change in either sex in any of the Indian population-based cancer registries. These
researchers suggest that "although traditional forms of tobacco chewing habits appear
to have decreased, they have perhaps only been replaced by smoking and have not
affected incidence rates of oral cancer". A study by Cox et al (1995) found that mouth
cancer incidence rose risen significantly in both males and females in New Zealand
between 1955-1991.
Mouth cancer accounted for 226 deaths over the 2}-year period i.e. 40.0Vo of all oral
cancer deaths and 53.3Vo of intraoral cancer deaths (See Table 10). The age-
t52
standardised mortality rates were low, with the male rate rarely exceeding 1.0 per
100,000 per annum and the female rate staying below 0.5 per 100,000 per annum for
all but two years. Importantly, these mortality rates remained stable over the 2l-year
period in both sexes. This contrasts with the increasing mortality from mouth cancer
reported for France (Hlll et al 1997), England (Hindle et al 1996), Japan (Zheng et al
1999; Su et al 7999), and New Zealand (Cox et al 1995).
Looking at individual sites of mouth cancer, the floor of mouth is an important site for
intraoral cancer with 5.6Vo of all oral cancers and 21.87o of intraoral cancers occurring
at this site. This finding provides further suppofi for the previously discussed
Lederman's hypothesis (Mashberg et al 1989) which proposes that the pooling of
carcinogens in saliva in oral food channels or "guttet zones" (Johnson &.
Wamakulasuriya 1993) increases the risk of oral cancer developing at these sites. The
number of deaths from gum cancer is another interesting finding. Although mortality
rates were not carried out for these sites due to the small number of cases reported, the
31 deaths from gum cancer appears high considering only 70 new cases of
malignancy were reported at this site in the 2}-year period. Using the D/R ratio
(Binnie 1916; Hindle & Nally 1991) as a crude measure of survival over the 2}-year
period, gum cancer has a ratio of 0.53:1 compared to tongue cancer 0.44:1, mouth
cancer 0.39:1 and lip cancer 0.01:1. The reason gum cancer in South Australia was so
lethal between 19ll-1996 is not known, but the data should be further investigated
using the more accurate measure of 5-year survival rates.
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5.6 Salivary Gland Cancer I42 (lCD'g)
The unique epidemiology and histopathology of salivary gland neoplasms provides
strong evidence that they should be considered as a distinct cancer site, separate from
other forms of oral cancer, i.e. lip and intraoral. This proposal is strongly supported by
the findings in South Australia between 1971-1996.
The general trends in terms of site of occumence of salivary gland malignancies
followed expected trends, with the vast majority (almost 8O7o) occurring in the
parotid gland. The next most common site was the submandibular gland (13.2Vo) with
the remaining cases occurring in unspecified gland (6.0Vo), overlapping sites (1.3Vo)
and the sublingual gland (O.l7o). V/hile a specific analysis was not carried out of
salivary gland malignancies in the minor glands, Table 8 indicates that these
neoplasms were reported elsewhere in the mouth. The histopathology of salivary
gland cancer in South Australia over the 2}-year period presents a not unexpected
variety of tumour types. The dominant forms of cancer occurring in the salivary
glands were mucoepidermoid carcinoma (21.57o), squamous cell carcinoma (73.9Vo),
adenoid cystic carcinoma (10.27o), acinar (acinic) cell carcinoma (10.27o),
adenocarcinoma NOS (9.67o) and malignant mixed tumour (1'07o).
As with other forms of oral cancer, salivary gland cancer occurred more frequently in
elderly patients with the average age at diagnosis being 61.4 years in males and 61.9
years in females. This is confirmed by the highly significant statistical association
between salivary gland cancer incidence and increasing patient age in both sexes. As
with other types of oral cancer, salivary gland cancer occurred more commonly in
males than females. It is interesting to note, however, that of the small number of
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cases of salivary gland cancer reported in patients under 25 years of age (2.6% of all
cases), J5Vo occuned in females.
The incidence of salivary gland cancer in South Australia between l9ll-1996 was
comparable to, or slightly higher than, most other parts of the world. The age-
standardised male rate rarely exceeded 1.5 per 100,000 per annum and the female rate
only rose above 1.0 per 100,000 per annum once, in 1983. There was no significant
change in the incidence rates of salivary gland cancer in either sex over the 20-year
period. There is limited published data on incidence rates of salivary gland cancer
elsewhere in the world. Devesa et al (1995) reported that incidence rates for salivary
gland cancer in the United States were stable in males between 1975-1991 and had
fallen in females over the same period. In a more localised study, Horn-Ross ¿r a/
(1991) noted a sudden and unexplained doubling in the incidence of salivary gland
cancer among men only at the San Francisco-Oakland registry during the second part
of the 1980's. In an extensive study of malignant salivary gland tumours in Sweden
over the past three decades, Ostman et al (1997) reported a relatively stable overall
incidence in both males and females, while noting variations in specific giands/
subsites. Hindle and Nally (1991) reported a decrease in the number of cases of
salivary gland cancer in England and'Wales in both sexes from 1962-7 to 1980-4.
In South Australia, salivary gland cancer accounted for 106 deaths (i.e. 18.8Vo of all
oral cancer deaths) over the Z}-year period. The age-standardised mortality rates were
low with the male rate rarely exceeding 0.5 per 100,000 per annum and the female
rate staying at or below 0.3 per 100,000 per annum for all but two years. These
mortality rates remained stable over the 2}-year period in both sexes.
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5.7 The Need For Future Studies
This study of the epidemiology of oral cancer in South Australia over a 2}-year period
has raised some interesting questions and invites further investigation. More detailed
analysis of the oral cancer data from the South Australian Cancer Registry and more
extensive studies could be carried out. These might include:
i. Five-year survival rates
More detailed analysis of the lethality of oral cancer and particularly changes over the
past decades could provide important information about the effectiveness of public
health awareness measures, early diagnosis and treatment regimes. Other researchers
(Gerson 1990; Johnson 1991; Daftary et al 7992; Antoniades et al 1995) have noted
the relatively poor survival from oral cancer (excluding the lip), and it would be
important to assess where South Australia stands in this regard.
ii. Age-specific cohort trends
Calculation of cancer incidence for various age cohorts by year of birth allows
assessment of changes in occurrence within various age groups. Significant changes
have been observed elsewhere in the world (Chen et al 7990a; Plesko et al 1994) and
it would be interesting to see whether these are reflected in the South Australian data.
iii. Geographic trends
Geographic trends have been studied in terms of urban versus rural differences in
cancer incidence and mortality (Schouten et al 1996). For oral cancer, this has been
particularly related to lip cancer where sunlight is felt to be a key risk factor. The data




The rates of cancer incidence and mortality vary widely between different populations
of the world. These variations could reflect differences in genetic predisposition
and/or specific causative environmental factors of cancer. The study of migrant
populations which change environments while retaining their genes, has been seen as
a "natural experiment" to test the relative importance of genetic and environmental
factors (Armstrong & McMichael 1984). Migrant studies have shown significantly
raised risks of oral cancer for both Indian (Swerdlow et al 1995b) and African
immigrants (Swerdlow et al 1992) to England and Wales. The best migrant studies
compare the overall cancer rates in both the original and host countries with the
migrant group. One such study on British and New Zealand migrant populations
clearly demonstrated ethnic trends, especially in lip and salivary gland tumours
(Swerdlow et al 7995a). Because of Australia's unique ethnic makeup, the result of
decades of immigration, Armstrong and McMichael (1984) have described this nation
as "a largely unused laboratory of natural experiments in human epidemiology". The
South Australian cancer data could become a basis for further migrant studies into the
various forms of oral cancer.
v. Aetiologic studies
Further research into the aetiology of oral cancer in South Australia is indicated. The
important finding from this study that South Australia leads the world in lip cancer
incidence, make it an obvious location for more detailed investigation into the risk









This study analysed the epidemiology of oral cancer in South Australia between l9l7-
1996. The more important findings and conclusions are:
o Evidence of an extremely high incidence of lip cancer in South Australia over the
past 20 years. Male rates remain amongst the highest in the world although the
incidence has plateaued in recent years. Female rates are also high and have
continued to steadily increase between 1911-1996.
o The vast majority of oral cancer cases in South Australia between 1911-1996,
occurred on the lip. This dominance by the lip site emphasises the importance of
using a site-specific classification system in epidemiological studies of oral
cancer. Combining all sites/subsites under the generic term "oral cancer" has the
potential to mask trends in the individual sites.
o Other forms of oral cancer in South Australia have shown relatively low but stable
incidence rates over the 2}-year analysis period. The observation that rates are not
decreasing points to the need for increasing public awareness of this disease,
particularly the importance of exposure to known risk factors such as smoking and
alcohol consumption.
o There is a need for further studies into the epidemiology of oral cancer,







No. 70 of 1976
An act to amend the Health Act,1935-1975
(Assented to2nd December, 1976)
The following heading and section are enacted and inserted
in the principal Act after section l46X thereof:
PART IXE
CANCER REPORTING
146Y. In this Part "cancer" means a malignant growth of
human tissue which if unchecked, is likely to spread to
adjacent tissue or beyond its place of origin, and which
has the propensity to recur, and includes carcinoma, sarcoma,
any mixed tumour, leukaemia, any type of lymphoma, and
melanoma but does not include any type of neoplasm
of the skin other than melanoma.
1462. (l) The owner of occupier of any building used as a
hospital shall, as soon as he or his manager or superintendent
becomes aware that an inmate is suffering from cancer,












(2) The person in charge of any place where
pathological examination of specimens of human origin is
undertaken shall, where any such examination indicates that
the person from whom the specimen was taken is suffering
from cancer, cause a copy of any report upon that examination
to be forwarded to the Central Board.
Source: Bonett A, Roder D (1988). Epidemiology of Cancer in South Australia.
lncidence, Mortality and Survival 1977 to 1986. Incidence and Mortality






Example of matrix used to calculate













































































































































based age-standardised incidence and mortality rates
40ICD-9) incidence in South Australia, 1977-1996

































































































































































Example of matrix used to calculate popt
Shows calculation for liP cancer I
Appendix II cont.
rlation-based age-standardised incidence and mortality rates
[40 ICD-9) incidence in South Australia, 1977'1996
YEAR9O




































































































































































































































































































































Example of matrix used to calculate population-based age-standardised incidence and mortality rates





































































































































































































































































































































































































































































Example of matrix used to calculate population-based age-standardised incidence and mortality rates




































































































































































































































































































































































































































































Example of matrix used to calculate population-based age-standardised incidence and mortality rates























































































1 6378 1 7933
1 7479 1 1233
1.0144 0.6953
07260 0.9432
















0 0000 0 1510
0.1346 0.1302
9 9433 10.5884
0 3739 1 3587
122995 13 0002
7 5870 8.1766


























































































































































































































































































































































Example of matrix used to calculate population-based age-standardised incidence and mortality rates





















































































































































































































































































































2 107 5 1.3251
2 1579 1.6644
1 2391 2 0548
1.0678 1.3656
0.8354 0 4344
0 8852 0 8460
0.0000 0.0000
0 0000 0 0000








0 1554 0 1543
0 3620 0 3696
03437 02311


































































































































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral cancer, 1977-1996
Presented by sex and site showing 957o confidence limits
Oral Cancer (140-5 ICD-9) - Incidence
t977 1978
World standard M 14.8484 14.4409
World standard F 1.8605 3.6430
Cl upper M 17.7149 17.2613
Cl lower M 11.9819 11.6204
Cl upper F 2.8226 4.9543
Cl lower F 0.8984 2.3317
Oral Cancer (140-5 ICD-9) - Incidence
1987 1988
World standard M 19.7009 19.3459
World standard F 5.2832 5.9859
Cl upper M 22.7548 22.3317
Gl lower M 16.6470 16.3602
Cl upper F 6.7359 7.5362
Cl lower F 3.8304 4.4356
































































































































































































South Australian age-standardised incidenci and mortality rates (per 100,000 per annum) for oral cancer, lg77-1996
Presented by sex and site showing 957o confidence limits
Lip Cancer (140 ICD-9) - Incidence
1987 1988
World standard M 14.9103 143626
World standard F 2.3154 3.2877
Gl upper M 17.5757 16.9293
Cl lower M 12.2449 11.7959
Cl upper F 3.2748 4.4591
Cl lower F 1.3561 2.1163
Tongue Cancer (141 ICD-9) - Incidence
t977 1978
World standard M 1.6528 1.3244
World standard F 0.6456 0.7531
Cl upper M 2.5906 2.1997
Cl lower M 0.7149 0.4492
Cl upper F 1.1910 1.3437
Cl lower F 0.1003 0.1625
































































































































































































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral cancer, 1977-1996
Presented by sex and site sh owing 957o confidence limits
Mouth Cancer (143-5 ICD-9) - Incidence
1977 1978
World standard M 2.2632 1.6821
World standard F 0.2555 0.9107
Cl upper M 3.3793 2.6354
Cl lower M 1.1471 0.7289
Cl upper F 0.6377 1.5299
Cl lower F -0.1268 0.2915
Mouth Cancer (143-5 ICD-9) - Incidence
1987 1988
World standard M 1.9941 2.5279
World standard F 1.2592 1.7292
Cl upper M 2.9863 3.6233
Cl lower M 1.0019 1.4324
Cl upper F 1.9432 2.5393
Cl lower F 0.5753 0.9191
































































































































































































South Australian age-standardised incidence lnd mortality rates (per 100,000 per annum) for oral cancer, 1977-1996
Presented by sex and site showing 957o confidence limits
Gum Cancer (143 ICD-9) - Incidence
1987 1988
World standard M 0.3934 0.6991
World standard F 0.0784 0.1 156
Cl upper M 0.8454 1'2693
Cl lower M -0.0586 0.1289
Cl upper F 0.2321 0-3420































































































































Floor of Mouth Cancer (l44lCD-g) - Incidence
t977 1978 1979
World standard M 0.8532 1.2532 1-1702
World standard F 0.0758 0.5210 0.6309
Cl upper M 1.5372 2'0735 1.9918
Cl lower M 0.1693 0.4329 0.3486
Cl upper F 0.2243 1.0326 1'1600
Cl lower F -0.0727 0.0094 0.1018


























































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral cancer' 1977'1996
Presented by sel and site showing 95o/" confidence limits
Other Mouth Cancer (145 ICD-9) - Incidence
t977 1978 1979
World standard M 1.4100 0.2885 0.2346
World standard F 0.'1797 0.2492 0.5839
Cl upper M 2.2920 0.6886 0.5596
Cl lower M 0.5280 -0.1116 -0'0905
Cl upper F 0.5319 0.5381 1.1119
Cl lower F -0.1725 -0.0397 0.0558
Other Mouth Cancer (145 ICD-9) - Incidence
1987 1988 1989
World standard M 0.9355 1 .0139 0.9552
World standard F 0.8404 0.9053 0.9316
Cl upper M 1.5927 1'7272 1'5876
Cl lower M 0.2783 0'3006 0.3228
Cl upper F 1.4002 1.4866 1.5620
Cl lower F 0.2806 0.3239 0.3012
Saliva4y Gland Cancer (l42lCD-g) - Incidence
1977 1978 1979
World standard M 0.9891 0.8459 2.0089
World standard F 0.5855 0.6205 0.4451
Cl upper M 11236 1.5265 3.0333
Cl lower M 0.2546 0.1653 0.9845
Cl upper F 1.1660 1.2049 0.8479






















































































































































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral cancer, 1977-1996
Presented by sex and site showing 957o confidence limits























































































































Oral Cancer (140-5 ICD-9) - Mortality
1977 1978
World standard M 1.8558 2.2373
World standard F 0.5246 0-7481
Cl'upper M 2.8679 3.3410
Cl lower M 0.8437 1'1336
Cl upper F 1.0237 1.3293
Cl lower F 0.0254 0.1670
Oral Cancer (140-5 ICD-9) - Mortality
t987 1988
World standard M 2.1906 2.1670
World standard F 0.5823 0.3851
Cl upper M 3.1452 3.1350
Cl lower M 1.2360 1.1990
Clupper F 1.0938 0.6804









































































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral cancer, 1977-1996
Presented by sex and site showing 957o confidence limits
Lip Cancer (140 ICD-9) - Mortality
Lip Cancer (140 ICD-9) - Mortalify
t987 1988
World standard M 0.1171 0.0724
World standard F 0.3059 0.0000
Cl upper M 0.3466 0.2143
Cl lower M -0.1124 -0.0695
Cl upper F 0.7319 0,0000
Cl lower F -0.1201 0.0000


















































































































































































































South Australian age-standardised incid
Presented
Tongue Cancer (141 ICD-9) - Mortality
100,000 per annum) for oral cancer, 1977-1996
confidence limits









































































































































































































































South Australian age-standardised incidence and mortality rates (per 100,000 per annum) for oral câncer' lg77-1996
Presented by sex and site showing 957o confidence limits
Salivary Gland Cancer (142ICD'9) - Mortality




























































































































































Example of Poisson regression analysis carried out to assess time trends in
incidence and mortality rates. Shows calculation for lip cancer (140 ICD-9)
incidence in South Australian males.
Lip cancer incidence: nales
The LOGISTIC Procedure
Datå Set: IYORK.LIP
Response Variable (Events): LCASE
Response Variable (Trials): PoP



















1381.703 with 2 0F 1p=6.ggg1¡
1448.014 with 2 DF 1p=9.gggt,
1 EVENT
2 NO EVENT
IVARNING: 83 observation(s) were deleted due to nissing values for the response or explanatory
variables.












AnalysÍs of Maxinu¡r Likelihood Estinates
Paraneter Standard Wal<l




















NOTE: Measures of association between the observed and predicted values were not calculated
because the predicted probabilities are indistinguishable when they are classified into
intervals of length 0.002
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Appendix IV cont.
Example of Poisson regression analysis carried out to assess time trends in
incidence and mortality rates. Shows calculation for lip cancer (140 ICD-9)
incidence in South Australian males.
Lip cancer incidence: males
The LoGISTIC Procedure
Data Set: lloRK.LIP
Response Variable (Events): LCASE
Response Vaniable (Trials): PoP






2 N0 EVENT 9332603
IÏARNING: 83 observation(s) were deleted due to missing values for the response or explanatory
variables.


















14O1.698 with 6 DF 1p=9.9q91,
1474.1O2 with 6 DF 1p=9.9991,































































NOÍE: Measures of association between the observed and predicted values were not calculated
because the predicted probabilities are indistinguishable when they are classified into






Example of Poisson regression analysis carried out to assess time trends in
incidence and mortality rates. Shows calculation for lip cancer (140 ICD-9)
incidence in South Australian males.
Lip cancer incidence: oales
The LOGISTIC Procedure
Data Set: woRK.LIP
Response VarÍable (Events): LCASE
Response variable (Trials): PoP








140f.698 with 6 DF
1474.1O2 with 6 DF
1 EVENT
2 NO EVENT
IYARNIilG: 83 observation(s) were deleted due to nissing values for the response or explanatory
variables.
















3799f .961 p=0. o001
p=0. 0001
variable
Analysis of Maxi-oun Likelihood Estirates
Paraneter Standard Ulald Pr >



























































I'IOTE: Measures of association between the observed and predicted values yvere not calculated
because the predicted probabilities are indistingufshable when they are classified into
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